{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:29:16Z","timestamp":1774870156615,"version":"3.50.1"},"reference-count":330,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00210-008-0322-7","type":"journal-article","created":{"date-parts":[[2008,7,14]],"date-time":"2008-07-14T05:00:14Z","timestamp":1216011614000},"page":"371-394","source":"Crossref","is-referenced-by-count":28,"title":["Current and prospective pharmacological targets in relation to antimigraine action"],"prefix":"10.1007","volume":"378","author":[{"given":"Suneet","family":"Mehrotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayi Y.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos M.","family":"Villal\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Centuri\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod R.","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,15]]},"reference":[{"key":"322_CR1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1749-6632.1967.tb41228.x","volume":"139","author":"RP Ahlquist","year":"1967","unstructured":"Ahlquist RP (1967) Development of the concept of alpha and beta adrenotropic receptors. Ann N Y Acad Sci 139:549\u2013552","journal-title":"Ann N Y Acad Sci"},{"key":"322_CR2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/jpet.105.083139","volume":"314","author":"S Akerman","year":"2005","unstructured":"Akerman S, Goadsby PJ (2005) The role of dopamine in a model of trigeminovascular nociception. J Pharmacol Exp Ther 314:162\u2013169","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1468-2982.2007.01478.x","volume":"27","author":"S Akerman","year":"2007","unstructured":"Akerman S, Goadsby PJ (2007) Dopamine and migraine: biology and clinical implications. Cephalalgia 27:1308\u20131314","journal-title":"Cephalalgia"},{"key":"322_CR4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(01)01111-6","volume":"424","author":"S Akerman","year":"2001","unstructured":"Akerman S, Williamson DJ, Hill RG, Goadsby PJ (2001) The effect of adrenergic compounds on neurogenic dural vasodilatation. Eur J Pharmacol 424:53\u201358","journal-title":"Eur J Pharmacol"},{"key":"322_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(02)03485-6","volume":"956","author":"S Akerman","year":"2002","unstructured":"Akerman S, Williamson DJ, Kaube H, Goadsby PJ (2002) The role of histamine in dural vessel dilation. Brain Res 956:96\u2013102","journal-title":"Brain Res"},{"key":"322_CR6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.bjp.0705456","volume":"140","author":"S Akerman","year":"2003","unstructured":"Akerman S, Williamson DJ, Goadsby PJ (2003) Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol 140:558\u2013566","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"322_CR7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/sj.bjp.0707199","volume":"150","author":"SP Alexander","year":"2007","unstructured":"Alexander SP, Mathie A, Peters JA (2007) Guide to receptors and channels, 2nd edition (2007 revision). Br J Pharmacol 150(Suppl 1):S1","journal-title":"Br J Pharmacol"},{"key":"322_CR8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00002508-200305000-00004","volume":"19","author":"AM Aloisi","year":"2003","unstructured":"Aloisi AM (2003) Gonadal hormones and sex differences in pain reactivity. Clin J Pain 19:168\u2013174","journal-title":"Clin J Pain"},{"key":"322_CR9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/jnnp.52.2.182","volume":"52","author":"M Anthony","year":"1989","unstructured":"Anthony M, Lance JW (1989) Plasma serotonin in patients with chronic tension headaches. J Neurol Neurosurg Psychiatry 52:182\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"322_CR10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archneur.1967.00470230096013","volume":"16","author":"M Anthony","year":"1967","unstructured":"Anthony M, Hinterberger H, Lance JW (1967) Plasma serotonin in migraine and stress. Arch Neurol 16:544\u2013552","journal-title":"Arch Neurol"},{"key":"322_CR11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/309163a0","volume":"309","author":"JR Arch","year":"1984","unstructured":"Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S (1984) Atypical \u03b2-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163\u2013165","journal-title":"Nature"},{"key":"322_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejphar.2004.07.035","volume":"500","author":"U Arulmani","year":"2004","unstructured":"Arulmani U, MaassenVanDenBrink A, Villal\u00f3n CM, Saxena PR (2004) Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 500:315\u2013330","journal-title":"Eur J Pharmacol"},{"key":"322_CR13","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1468-2982.2005.00967.x","volume":"25","author":"U Arulmani","year":"2005","unstructured":"Arulmani U, Heiligers JPC, Centuri\u00f3n D, Garrelds IM, Villal\u00f3n CM, Saxena PR (2005) Lack of effect of the adenosine A1 receptor agonist, GR79236, on capsaicin-induced CGRP release in anaesthetized pigs. Cephalalgia 25:1082\u20131090","journal-title":"Cephalalgia"},{"key":"322_CR14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1468-2982.2005.01082.x","volume":"26","author":"U Arulmani","year":"2006","unstructured":"Arulmani U, Gupta S, MaassenVanDenBrink A, Centuri\u00f3n D, Villal\u00f3n CM, Saxena PR (2006) Experimental migraine models and their relevance in migraine therapy. Cephalalgia 26:642\u2013659","journal-title":"Cephalalgia"},{"key":"322_CR15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(97)00136-4","volume":"756","author":"G Attali","year":"1997","unstructured":"Attali G, Weizman A, Gil-Ad I, Rehavi M (1997) Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res 756:153\u2013159","journal-title":"Brain Res"},{"key":"322_CR16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/hrt.2004.053991","volume":"91","author":"T Attina","year":"2005","unstructured":"Attina T, Camidge R, Newby DE, Webb DJ (2005) Endothelin antagonism in pulmonary hypertension, heart failure, and beyond. Heart 91:825\u2013831","journal-title":"Heart"},{"key":"322_CR17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3940(96)12491-5","volume":"207","author":"P Barbanti","year":"1996","unstructured":"Barbanti P, Bronzetti E, Ricci A, Cerbo R, Fabbrini G, Buzzi MG, Amenta F, Lenzi GL (1996) Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci Lett 207:73\u201376","journal-title":"Neurosci Lett"},{"key":"322_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1468-2982.2000.00001.x","volume":"20","author":"P Barbanti","year":"2000","unstructured":"Barbanti P, Fabbrini G, Ricci A, Pascali MP, Bronzetti E, Amenta F, Lenzi GL, Cerbo R (2000) Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia 20:15\u201319","journal-title":"Cephalalgia"},{"key":"322_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","volume":"50","author":"EA Barnard","year":"1998","unstructured":"Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ (1998) International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291\u2013313","journal-title":"Pharmacol Rev"},{"key":"322_CR20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","volume":"38","author":"NM Barnes","year":"1999","unstructured":"Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083\u20131152","journal-title":"Neuropharmacology"},{"key":"322_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0091-3057(99)00091-X","volume":"64","author":"JB Becker","year":"1999","unstructured":"Becker JB, Rudick CN (1999) Rapid effects of estrogen or progesterone on the amphetamine-induced increase in striatal dopamine are enhanced by estrogen priming: a microdialysis study. Pharmacol Biochem Behav 64:53\u201357","journal-title":"Pharmacol Biochem Behav"},{"key":"322_CR22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1526-4610.1995.hed3508470.x","volume":"35","author":"WI Bender","year":"1995","unstructured":"Bender WI (1995) ACE inhibitors for prophylaxis of migraine headaches. Headache 35:470\u2013471","journal-title":"Headache"},{"key":"322_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(00)00242-6","volume":"86","author":"AD Bennett","year":"2000","unstructured":"Bennett AD, Chastain KM, Hulsebosch CE (2000) Alleviation of mechanical and thermal allodynia by CGRP(8\u201337) in a rodent model of chronic central pain. Pain 86:163\u2013175","journal-title":"Pain"},{"key":"322_CR24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.21077","volume":"61","author":"A Bergerot","year":"2007","unstructured":"Bergerot A, Storer RJ, Goadsby PJ (2007) Dopamine inhibits trigeminovascular transmission in the rat. Ann Neurol 61:251\u2013262","journal-title":"Ann Neurol"},{"key":"322_CR25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1468-2982.2002.00364.x","volume":"22","author":"ME Bigal","year":"2002","unstructured":"Bigal ME, Bordini CA, Tepper SJ, Speciali JG (2002) Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 22:345\u2013353","journal-title":"Cephalalgia"},{"key":"322_CR26","first-page":"323","volume":"259","author":"HS Blaxall","year":"1991","unstructured":"Blaxall HS, Murphy TJ, Baker JC, Ray C, Bylund DB (1991) Characterization of the \u03b12C- adrenergic receptor subtype in the opossum kidney and in the OK cell line. J Pharmacol Exp Ther 259:323\u2013329","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00002826-199102000-00008","volume":"14","author":"O Blin","year":"1991","unstructured":"Blin O, Azulay JP, Masson G, Aubrespy G, Serratrice G (1991) Apomorphine-induced yawning in migraine patients: enhanced responsiveness. Clin Neuropharmacol 14:91\u201395","journal-title":"Clin Neuropharmacol"},{"key":"322_CR28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1468-2982.1989.904239.x","volume":"9","author":"M Boccuni","year":"1989","unstructured":"Boccuni M, Alessandri M, Fusco BM, Cangi F (1989) The pressor hyperresponsiveness to phenylephrine unmasks sympathetic hypofunction in migraine. Cephalalgia 9:239\u2013245","journal-title":"Cephalalgia"},{"key":"322_CR29","first-page":"327P","volume":"94","author":"AH Bom","year":"1988","unstructured":"Bom AH, Saxena PR, Verdouw PD (1988) Further characterization of the 5-HT1-like receptors in the carotid circulation of the pigs. Br J Pharmacol 94:327P","journal-title":"Br J Pharmacol"},{"key":"322_CR30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1476-5381.1988.tb11698.x","volume":"95","author":"RA Bond","year":"1988","unstructured":"Bond RA, Clarke DE (1988) Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the \u03b1- and \u03b2-subtypes. Br J Pharmacol 95:723\u2013734","journal-title":"Br J Pharmacol"},{"key":"322_CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/pr.54.2.247","volume":"54","author":"NG Bowery","year":"2002","unstructured":"Bowery NG, Bettler B, Froestl W, Gallagher JP, Marshall F, Raiteri M, Bonner TI, Enna SJ (2002) International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol Rev 54:247\u2013264","journal-title":"Pharmacol Rev"},{"key":"322_CR32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1152\/physrev.00037.2003","volume":"84","author":"SD Brain","year":"2004","unstructured":"Brain SD, Grant AD (2004) Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84:903\u2013934","journal-title":"Physiol Rev"},{"key":"322_CR33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"291","author":"JL Brandes","year":"2004","unstructured":"Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D (2004) Topiramate for migraine prevention: a randomized controlled trial. JAMA 291:965\u2013973","journal-title":"JAMA"},{"key":"322_CR34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1054-3589(08)60076-9","volume":"39","author":"JM Brundege","year":"1997","unstructured":"Brundege JM, Dunwiddie TV (1997) Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv Pharmacol 39:353\u2013391","journal-title":"Adv Pharmacol"},{"key":"322_CR35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1586\/14737175.4.3.391","volume":"4","author":"TM Buchanan","year":"2004","unstructured":"Buchanan TM, Ramadan NM, Aurora S (2004) Future pharmacologic targets for acute and preventive treatments of migraine. Expert Rev Neurother 4:391\u2013430","journal-title":"Expert Rev Neurother"},{"key":"322_CR36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1526-4610.1996.3604254.x","volume":"36","author":"A Buchwalder","year":"1996","unstructured":"Buchwalder A, Welch SK, Peroutka SJ (1996) Exclusion of 5-HT2A and 5-HT2C receptor genes as candidate genes for migraine. Headache 36:254\u2013258","journal-title":"Headache"},{"key":"322_CR37","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/oxfordjournals.bja.a013473","volume":"84","author":"G Burnstock","year":"2000","unstructured":"Burnstock G (2000) P2X receptors in sensory neurones. Br J Anaesth 84:476\u2013488","journal-title":"Br J Anaesth"},{"issue":"Pt 8","key":"322_CR38","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/brain\/123.8.1703","volume":"123","author":"R Burstein","year":"2000","unstructured":"Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123(Pt 8):1703\u20131709","journal-title":"Brain"},{"key":"322_CR39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0165-6147(88)90254-4","volume":"9","author":"DB Bylund","year":"1988","unstructured":"Bylund DB (1988) Subtypes of \u03b12-adrenoceptors: pharmacological and molecular biological evidence converge. Trends Pharmacol Sci 9:356\u2013361","journal-title":"Trends Pharmacol Sci"},{"key":"322_CR40","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1096\/fasebj.6.3.1346768","volume":"6","author":"DB Bylund","year":"1992","unstructured":"Bylund DB (1992) Subtypes of \u03b11- and \u03b12-adrenergic receptors. Faseb J 6:832\u2013839","journal-title":"Faseb J"},{"key":"322_CR41","first-page":"600","volume":"245","author":"DB Bylund","year":"1988","unstructured":"Bylund DB, Ray-Prenger C, Murphy TJ (1988) \u03b1-2A and \u03b1-2B adrenergic receptor subtypes: antagonist binding in tissues and cell lines containing only one subtype. J Pharmacol Exp Ther 245:600\u2013607","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-6997(25)06780-8","volume":"46","author":"DB Bylund","year":"1994","unstructured":"Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121\u2013136","journal-title":"Pharmacol Rev"},{"key":"322_CR43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1139\/y95-068","volume":"73","author":"DB Bylund","year":"1995","unstructured":"Bylund DB, Regan JW, Faber JE, Hieble JP, Triggle CR, Ruffolo RR Jr (1995) Vascular \u03b1-adrenoceptors: from the gene to the human. Can J Physiol Pharmacol 73:533\u2013543","journal-title":"Can J Physiol Pharmacol"},{"key":"322_CR44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.SMJ.0000129924.15619.D9","volume":"97","author":"AH Calhoun","year":"2004","unstructured":"Calhoun AH (2004) A novel specific prophylaxis for menstrual-associated migraine. South Med J 97:819\u2013822","journal-title":"South Med J"},{"key":"322_CR45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","volume":"180","author":"A Carlsson","year":"1957","unstructured":"Carlsson A, Lindqvist M, Magnusson M (1957) 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180:1200","journal-title":"Nature"},{"key":"322_CR46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1126\/science.127.3296.471","volume":"127","author":"A Carlsson","year":"1958","unstructured":"Carlsson A, Lindqvist M, Magnusson T, Walbeck B (1958) On the presence of 3-hydroxytyramine in brain. Science 127:471","journal-title":"Science"},{"key":"322_CR47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1526-4610.1974.hed1403149.x","volume":"14","author":"JD Carroll","year":"1974","unstructured":"Carroll JD, Hilton BP (1974) The effects of reserpine injection on methysergide treated control and migrainous subjects. Headache 14:149\u2013156","journal-title":"Headache"},{"key":"322_CR48","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1124\/mol.59.6.1533","volume":"59","author":"AM Carruthers","year":"2001","unstructured":"Carruthers AM, Sellers LA, Jenkins DW, Jarvie EM, Feniuk W, Humphrey PPA (2001) Adenosine 1 receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons. Mol Pharmacol 59:1533\u20131541","journal-title":"Mol Pharmacol"},{"key":"322_CR49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1468-2982.2003.00441.x","volume":"23","author":"EM Cassidy","year":"2003","unstructured":"Cassidy EM, Tomkins E, Dinan T, Hardiman O, O\u2019Keane V (2003) Central 5-HT receptor hypersensitivity in migraine without aura. Cephalalgia 23:29\u201334","journal-title":"Cephalalgia"},{"key":"322_CR50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejphar.2004.08.050","volume":"502","author":"D Centuri\u00f3n","year":"2004","unstructured":"Centuri\u00f3n D, Glusa E, Sanchez-Lopez A, Valdivia LF, Saxena PR, Villal\u00f3n CM (2004) 5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats. Eur J Pharmacol 502:239\u2013242","journal-title":"Eur J Pharmacol"},{"key":"322_CR51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00002826-199702000-00004","volume":"20","author":"R Cerbo","year":"1997","unstructured":"Cerbo R, Barbanti P, Buzzi MG, Fabbrini G, Brusa L, Roberti C, Zanette E, Lenzi GL (1997) Dopamine hypersensitivity in migraine: role of the apomorphine test. Clin Neuropharmacol 20:36\u201341","journal-title":"Clin Neuropharmacol"},{"key":"322_CR52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejphar.2005.12.039","volume":"531","author":"W Chai","year":"2006","unstructured":"Chai W, Mehrotra S, Danser AHJ, Schoemaker RG (2006) The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts. Eur J Pharmacol 531:246\u2013253","journal-title":"Eur J Pharmacol"},{"key":"322_CR53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1526-4610.2006.00382.x","volume":"46","author":"JA Charles","year":"2006","unstructured":"Charles JA, Jotkowitz S, Byrd LH (2006) Prevention of migraine with olmesartan in patients with hypertension\/prehypertension. Headache 46:503\u2013507","journal-title":"Headache"},{"key":"322_CR54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0006-8993(01)02550-1","volume":"907","author":"JD Classey","year":"2001","unstructured":"Classey JD, Knight YE, Goadsby PJ (2001) The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Brain Res 907:117\u2013124","journal-title":"Brain Res"},{"key":"322_CR55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cne.903090209","volume":"309","author":"JR Clements","year":"1991","unstructured":"Clements JR, Magnusson KR, Hautman J, Beitz AJ (1991) Rat tooth pulp projections to spinal trigeminal subnucleus caudalis are glutamate-like immunoreactive. J Comp Neurol 309:281\u2013288","journal-title":"J Comp Neurol"},{"key":"322_CR56","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0301-0082(96)00033-0","volume":"50","author":"Z Cohen","year":"1996","unstructured":"Cohen Z, Bonvento G, Lacombe P, Hamel E (1996) Serotonin in the regulation of brain microcirculation. Prog Neurobiol 50:335\u2013362","journal-title":"Prog Neurobiol"},{"key":"322_CR57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10048-004-0181-4","volume":"5","author":"NJ Colson","year":"2004","unstructured":"Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR (2004) The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case\/control groups. Neurogenetics 5:129\u2013133","journal-title":"Neurogenetics"},{"key":"322_CR58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10048-004-0205-0","volume":"6","author":"NJ Colson","year":"2005","unstructured":"Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR (2005) Investigation of hormone receptor genes in migraine. Neurogenetics 6:17\u201323","journal-title":"Neurogenetics"},{"key":"322_CR59","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0028-3908(97)00132-9","volume":"36","author":"SP Cook","year":"1997","unstructured":"Cook SP, McCleskey EW (1997) Desensitization, recovery and Ca(2+)-dependent modulation of ATP-gated P2X receptors in nociceptors. Neuropharmacology 36:1303\u20131308","journal-title":"Neuropharmacology"},{"key":"322_CR60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/387505a0","volume":"387","author":"SP Cook","year":"1997","unstructured":"Cook SP, Vulchanova L, Hargreaves KM, Elde R, McCleskey EW (1997) Distinct ATP receptors on pain-sensing and stretch-sensing neurons. Nature 387:505\u2013508","journal-title":"Nature"},{"key":"322_CR61","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1073\/pnas.85.19.7159","volume":"85","author":"S Cotecchia","year":"1988","unstructured":"Cotecchia S, Schwinn DA, Randall RR, Lefkowitz RJ, Caron MG, Kobilka BK (1988) Molecular cloning and expression of the cDNA for the hamster \u03b11-adrenergic receptor. Proc Natl Acad Sci USA 85:7159\u20137163","journal-title":"Proc Natl Acad Sci USA"},{"key":"322_CR62","first-page":"9","volume-title":"B-blockers in clinical practice","author":"JM Cruickshank","year":"1994","unstructured":"Cruickshank JM, Prichard BN (1994) Beta-adrenoceptors.. In: Cruickshank JM, Prichard BNC (eds) B-blockers in clinical practice. Churchill Livingstone, Edinburgh, pp 9\u201386"},{"key":"322_CR63","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/brain\/88.5.997","volume":"88","author":"DA Curran","year":"1965","unstructured":"Curran DA, Hinterberger H, Lance JW (1965) Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 88:997\u20131010","journal-title":"Brain"},{"issue":"Suppl. 1","key":"322_CR64","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1526-4610.2001.01154-2.x","volume":"41","author":"FM Cutrer","year":"2001","unstructured":"Cutrer FM (2001) Antiepileptic drugs: how they work in headache. Headache 41(Suppl. 1):S3\u201310","journal-title":"Headache"},{"key":"322_CR65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1468-2982.1997.1702093.x","volume":"17","author":"FM Cutrer","year":"1997","unstructured":"Cutrer FM, Limmroth V, Moskowitz MA (1997a) Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia 17:93\u2013100","journal-title":"Cephalalgia"},{"key":"322_CR66","first-page":"59","volume-title":"Headache","author":"FM Cutrer","year":"1997","unstructured":"Cutrer FM, Limmroth V, Waeber C, Yu X, Moskowitz MA (1997b) New targets for antimigraine drug development. In: Goadsby PJ, Silberstein S (eds) Headache. Butterworth-Heinemann, Philadelphia, pp 59\u201372"},{"key":"322_CR67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-0173(01)00115-1","volume":"37","author":"M Cyr","year":"2001","unstructured":"Cyr M, Ghribi O, Thibault C, Morissette M, Landry M, Di Paolo T (2001) Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res Rev 37:153\u2013161","journal-title":"Brain Res Rev"},{"key":"322_CR68","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1046\/j.1468-2982.1998.1809593.x","volume":"18","author":"CG Dahl\u00f6f","year":"1998","unstructured":"Dahl\u00f6f CG, Hargreaves RJ (1998) Pathophysiology and pharmacology of migraine. Is there a place for antiemetics in future treatment strategies. Cephalalgia 18:593\u2013604","journal-title":"Cephalalgia"},{"key":"322_CR69","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1526-4610.2006.00407.x","volume":"46","author":"G D\u2019Andrea","year":"2006","unstructured":"D\u2019Andrea G, Granella F, Perini F, Farruggio A, Leone M, Bussone G (2006) Platelet levels of dopamine are increased in migraine and cluster headache. Headache 46:585\u2013591","journal-title":"Headache"},{"key":"322_CR70","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","volume":"52","author":"M Gasparo De","year":"2000","unstructured":"De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415\u2013472","journal-title":"Pharmacol Rev"},{"key":"322_CR71","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/14728214.4.1.107","volume":"4","author":"P Vries De","year":"1999","unstructured":"De Vries P, Villal\u00f3n CM, Saxena PR (1999a) Pharmacology of triptans. Emerging Drugs 4:107\u2013125","journal-title":"Emerging Drugs"},{"key":"322_CR72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(99)00197-1","volume":"375","author":"P Vries De","year":"1999","unstructured":"De Vries P, Villal\u00f3n CM, Saxena PR (1999b) Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. Eur J Pharmacol 375:61\u201374","journal-title":"Eur J Pharmacol"},{"key":"322_CR73","first-page":"137","volume":"3","author":"E Del Bene","year":"1983","unstructured":"Del Bene E, Poggioni M, Michelacci S (1983) Lisuride as a migraine prophylactic in children: an open clinical trial. Int J Clin Pharmacol Res 3:137\u2013141","journal-title":"Int J Clin Pharmacol Res"},{"key":"322_CR74","first-page":"145","volume":"151","author":"G Trapani Di","year":"2000","unstructured":"Di Trapani G, Mei D, Marra C, Mazza S, Capuano A (2000) Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. Clin Ter 151:145\u2013148","journal-title":"Clin Ter"},{"key":"322_CR75","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00415-004-0464-6","volume":"251","author":"HC Diener","year":"2004","unstructured":"Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJ, Sandrini G, Wang SJ, Neto W, Vijapurkar U, Doyle A, Jacobs D (2004) Topiramate in migraine prophylaxis\u2014results from a placebo-controlled trial with propranolol as an active control. J Neurol 251:943\u2013950","journal-title":"J Neurol"},{"key":"322_CR76","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(89)90150-9","volume":"494","author":"DE Dluzen","year":"1989","unstructured":"Dluzen DE, Ram\u00edrez VD (1989) Progesterone enhances l-dopa-stimulated dopamine release from the caudate nucleus of freely behaving ovariectomized-estrogen-primed rats. Brain Res 494:122\u2013128","journal-title":"Brain Res"},{"key":"322_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00682-7","volume":"361","author":"JR Docherty","year":"1998","unstructured":"Docherty JR (1998) Subtypes of functional \u03b11- and \u03b12-adrenoceptors. Eur J Pharmacol 361:1\u201315","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"322_CR78","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1526-4610.2004.04105.x","volume":"44","author":"DW Dodick","year":"2004","unstructured":"Dodick DW, Martin VT, Smith T, Silberstein S (2004) Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache 44(Suppl 1):S20\u2013S30","journal-title":"Headache"},{"key":"322_CR79","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","volume":"129","author":"H Doods","year":"2000","unstructured":"Doods H, Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W, Eberlein W (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129:420\u2013423","journal-title":"Br J Pharmacol"},{"key":"322_CR80","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/brain\/awf007","volume":"125","author":"JP Dreier","year":"2002","unstructured":"Dreier JP, Kleeberg J, Petzold G, Priller J, Windmuller O, Orzechowski HD, Lindauer U, Heinemann U, Einhaupl KM, Dirnagl U (2002) Endothelin-1 potently induces Leao\u2019s cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura. Brain 125:102\u2013112","journal-title":"Brain"},{"key":"322_CR81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410130108","volume":"13","author":"PD Drummond","year":"1983","unstructured":"Drummond PD, Lance JW (1983) Extracranial vascular changes and the source of pain in migraine headache. Ann Neurol 13:32\u201337","journal-title":"Ann Neurol"},{"key":"322_CR82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1468-2982.1984.0403149.x","volume":"4","author":"PD Drummond","year":"1984","unstructured":"Drummond PD, Lance JW (1984) Facial temperature in migraine, tension-vascular and tension headache. Cephalalgia 4:149\u2013158","journal-title":"Cephalalgia"},{"key":"322_CR83","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1139\/y97-079","volume":"75","author":"Y Dumont","year":"1997","unstructured":"Dumont Y, Fournier A, St-Pierre S, Quirion R (1997) A potent and selective CGRP2 agonist, [Cys(Et)2,7]hCGRP alpha: comparison in prototypical CGRP1 and CGRP2 in vitro bioassays. Can J Physiol Pharmacol 75:671\u2013676","journal-title":"Can J Physiol Pharmacol"},{"key":"322_CR84","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJMp048016","volume":"350","author":"PL Durham","year":"2004","unstructured":"Durham PL (2004) CGRP-receptor antagonists\u2014a fresh approach to migraine therapy. N Engl J Med 350:1073\u20131075","journal-title":"N Engl J Med"},{"key":"322_CR85","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1468-2982.2003.00719.x","volume":"24","author":"L Edvinsson","year":"2004","unstructured":"Edvinsson L (2004) Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 24:611\u2013622","journal-title":"Cephalalgia"},{"key":"322_CR86","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1468-2982.1994.1405320.x","volume":"14","author":"L Edvinsson","year":"1994","unstructured":"Edvinsson L, Goadsby PJ (1994) Neuropeptides in migraine and cluster headache. Cephalalgia 14:320\u2013327","journal-title":"Cephalalgia"},{"key":"322_CR87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2796.1999.00545.x","volume":"246","author":"E Enmark","year":"1999","unstructured":"Enmark E, Gustafsson JA (1999) Oestrogen receptors\u2014an overview. J Intern Med 246:133\u2013138","journal-title":"J Intern Med"},{"key":"322_CR88","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-510X(01)00556-1","volume":"188","author":"ME Erdal","year":"2001","unstructured":"Erdal ME, Herken H, Yilmaz M, Bayazit YA (2001) Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine. J Neurol Sci 188:99\u2013101","journal-title":"J Neurol Sci"},{"key":"322_CR89","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0031-6997(25)07372-7","volume":"6","author":"V Erspamer","year":"1954","unstructured":"Erspamer V (1954) Pharmacology of indolealkylamines. Pharmacol Rev 6:425\u2013487","journal-title":"Pharmacol Rev"},{"key":"322_CR90","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/169800b0","volume":"169","author":"V Erspamer","year":"1952","unstructured":"Erspamer V, Asero B (1952) Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature 169:800\u2013801","journal-title":"Nature"},{"key":"322_CR91","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1523\/JNEUROSCI.0647-06.2006","volume":"26","author":"E Fabbretti","year":"2006","unstructured":"Fabbretti E, D\u2019Arco M, Fabbro A, Simonetti M, Nistri A, Giniatullin R (2006) Delayed upregulation of ATP P2X3 receptors of trigeminal sensory neurons by calcitonin gene-related peptide. J Neurosci 26:6163\u20136171","journal-title":"J Neurosci"},{"key":"322_CR92","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00006842-198909000-00006","volume":"51","author":"F Facchinetti","year":"1989","unstructured":"Facchinetti F, Martignoni E, Nappi G, Fioroni L, Sances G, Genazzani AR (1989) Premenstrual failure of \u03b1-adrenergic stimulation on hypothalamus\u2013pituitary responses in menstrual migraine. Psychosom Med 51:550\u2013558","journal-title":"Psychosom Med"},{"key":"322_CR93","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1526-4610.1991.hed3105298.x","volume":"31","author":"F Facchinetti","year":"1991","unstructured":"Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31:298\u2013301","journal-title":"Headache"},{"key":"322_CR94","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1468-2982.1992.00383.x","volume":"12","author":"M Farkkila","year":"1992","unstructured":"Farkkila M, Palo J, Saijonmaa O, Fyhrquist F (1992) Raised plasma endothelin during acute migraine attack. Cephalalgia 12:383\u2013384, discussion 340","journal-title":"Cephalalgia"},{"key":"322_CR95","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0091-3057(90)90262-G","volume":"36","author":"JJ Fern\u00e1ndez-Ru\u00edz","year":"1990","unstructured":"Fern\u00e1ndez-Ru\u00edz JJ, de Miguel R, Hern\u00e1ndez ML, Ramos JA (1990) Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain. Pharmacol Biochem Behav 36:603\u2013606","journal-title":"Pharmacol Biochem Behav"},{"key":"322_CR96","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1007\/BF01642907","volume":"1","author":"MD Ferrari","year":"1991","unstructured":"Ferrari MD (1991) 5-HT3 receptor antagonists and migraine therapy. J Neurol 238 Suppl 1:S53\u201356","journal-title":"J Neurol 238 Suppl"},{"key":"322_CR97","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-6147(93)90084-W","volume":"14","author":"MD Ferrari","year":"1993","unstructured":"Ferrari MD, Saxena PR (1993) Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci 14:129\u2013133","journal-title":"Trends Pharmacol Sci"},{"key":"322_CR98","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/jm00014a004","volume":"38","author":"IT Forbes","year":"1995","unstructured":"Forbes IT, Ham P, Booth DH, Martin RT, Thompson M, Baxter GS, Blackburn TP, Glen A, Kennett GA, Wood MD (1995) 5-Methyl-1-(3-pyridylcarbamoyl)-1,2,3,5-tetrahydropyrrolo[2,3-f]indole: a novel 5-HT2C\/5-HT2B receptor antagonist with improved affinity, selectivity, and oral activity. J Med Chem 38:2524\u20132530","journal-title":"J Med Chem"},{"key":"322_CR99","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-6147(94)90136-8","volume":"15","author":"AP Ford","year":"1994","unstructured":"Ford AP, Williams TJ, Blue DR, Clarke DE (1994) \u03b11-Adrenoceptor classification: sharpening Occam\u2019s razor. Trends Pharmacol Sci 15:167\u2013170","journal-title":"Trends Pharmacol Sci"},{"key":"322_CR100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1526-4610.1983.hed2304188.x","volume":"23","author":"B Forssman","year":"1983","unstructured":"Forssman B, Lindblad CJ, Zbornikova V (1983) Atenolol for migraine prophylaxis. Headache 23:188\u2013190","journal-title":"Headache"},{"key":"322_CR101","first-page":"225","volume":"350","author":"JR Fozard","year":"1994","unstructured":"Fozard JR, Kalkman HO (1994) 5-Hydroxytryptamine (5-HT) and the initiation of migraine: new perspectives. Naunyn-Schmiedeberg\u2018s Arch Pharmacol 350:225\u2013229","journal-title":"Naunyn-Schmiedeberg\u2018s Arch Pharmacol"},{"key":"322_CR102","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0014-2999(98)00744-4","volume":"361","author":"BJ Francken","year":"1998","unstructured":"Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE (1998) The human 5-ht5A receptor couples to Gi\/Go proteins and inhibits adenylate cyclase in HEK 293 cells. Eur J Pharmacol 361:299\u2013309","journal-title":"Eur J Pharmacol"},{"key":"322_CR103","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","volume":"53","author":"BB Fredholm","year":"2001","unstructured":"Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527\u2013552","journal-title":"Pharmacol Rev"},{"key":"322_CR104","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1515\/jom-1984-841214","volume":"84","author":"FG Freitag","year":"1984","unstructured":"Freitag FG, Diamond S (1984) Nadolol and placebo comparison study in the prophylactic treatment of migraine. J Am Osteopath Assoc 84:343\u2013347","journal-title":"J Am Osteopath Assoc"},{"key":"322_CR105","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.pain.2006.09.017","volume":"128","author":"E Fusayasu","year":"2007","unstructured":"Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K (2007) Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128:209\u2013214","journal-title":"Pain"},{"key":"322_CR106","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/sj.bjp.0701523","volume":"122","author":"J Galitzky","year":"1997","unstructured":"Galitzky J, Langin D, Verwaerde P, Montastruc JL, Lafontan M, Berlan M (1997) Lipolytic effects of conventional \u03b23-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative \u03b24-adrenoceptor. Br J Pharmacol 122:1244\u20131250","journal-title":"Br J Pharmacol"},{"key":"322_CR107","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0006-8993(99)02448-8","volume":"861","author":"MG Garry","year":"2000","unstructured":"Garry MG, Walton LP, Davis MA (2000) Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from the spinal cord is mediated by nitric oxide but not by cyclic GMP. Brain Res 861:208\u2013219","journal-title":"Brain Res"},{"key":"322_CR108","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0006-8993(90)90727-S","volume":"510","author":"P Geppetti","year":"1990","unstructured":"Geppetti P, Del Bianco E, Santicioli P, Lippe IT, Maggi CA, Sicuteri F (1990) Release of sensory neuropeptides from dural venous sinuses of guinea pig. Brain Res 510:58\u201362","journal-title":"Brain Res"},{"key":"322_CR109","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.yjmcc.2005.08.006","volume":"39","author":"S Ghelardoni","year":"2005","unstructured":"Ghelardoni S, Carnicelli V, Frascarelli S, Lankford A, Masala I, Ronca-Testoni S, Matherne GP, Zucchi R (2005) Effects of A1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis. J Mol Cell Cardiol 39:964\u2013971","journal-title":"J Mol Cell Cardiol"},{"key":"322_CR110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1468-2982.2003.00511.x","volume":"23","author":"NJ Giffin","year":"2003","unstructured":"Giffin NJ, Kowacs F, Libri V, Williams P, Goadsby PJ, Kaube H (2003) Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 23:287\u2013292","journal-title":"Cephalalgia"},{"key":"322_CR111","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.wco.0000169746.60029.e5","volume":"18","author":"PJ Goadsby","year":"2005","unstructured":"Goadsby PJ (2005) New targets in the acute treatment of headache. Curr Opin Neurol 18:283\u2013288","journal-title":"Curr Opin Neurol"},{"key":"322_CR112","first-page":"389","volume":"40","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Lance JW (1990) Physiopathology of migraine. Rev Prat 40:389\u2013393","journal-title":"Rev Prat"},{"key":"322_CR113","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0006-8993(00)02630-5","volume":"875","author":"PJ Goadsby","year":"2000","unstructured":"Goadsby PJ, Classey JD (2000) Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res 875:119\u2013124","journal-title":"Brain Res"},{"key":"322_CR114","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0306-4522(03)00570-0","volume":"122","author":"PJ Goadsby","year":"2003","unstructured":"Goadsby PJ, Classey JD (2003) Evidence for serotonin 5-HT1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience 122:491\u2013498","journal-title":"Neuroscience"},{"key":"322_CR115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","volume":"23","author":"PJ Goadsby","year":"1988","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193\u2013196","journal-title":"Ann Neurol"},{"key":"322_CR116","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/00004647-199607000-00021","volume":"16","author":"PJ Goadsby","year":"1996","unstructured":"Goadsby PJ, Adner M, Edvinsson L (1996) Characterization of endothelin receptors in the cerebral vasculature and their lack of effect on spreading depression. J Cereb Blood Flow Metab 16:698\u2013704","journal-title":"J Cereb Blood Flow Metab"},{"key":"322_CR117","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJMra010917","volume":"346","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Lipton RB, Ferrari MD (2002a) Migraine\u2014current understanding and treatment. N Engl J Med 346:257\u2013270","journal-title":"N Engl J Med"},{"key":"322_CR118","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/brain\/awf141","volume":"125","author":"PJ Goadsby","year":"2002","unstructured":"Goadsby PJ, Hoskin KL, Storer RJ, Edvinsson L, Connor HE (2002b) Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 125:1392\u20131401","journal-title":"Brain"},{"key":"322_CR119","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1468-2982.1997.1707785.x","volume":"17","author":"DJ Goldstein","year":"1997","unstructured":"Goldstein DJ, Wang O, Saper JR, Stoltz R, Silberstein SD, Mathew NT (1997) Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study. Cephalalgia 17:785\u2013790","journal-title":"Cephalalgia"},{"key":"322_CR120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1468-2982.2001.00161.x","volume":"21","author":"DJ Goldstein","year":"2001","unstructured":"Goldstein DJ, Offen WW, Klein EG, Phebus LA, Hipskind P, Johnson KW, Ryan RE Jr (2001a) Lanepitant, an NK-1 antagonist, in migraine prevention. Cephalalgia 21:102\u2013106","journal-title":"Cephalalgia"},{"key":"322_CR121","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(01)06347-4","volume":"358","author":"DJ Goldstein","year":"2001","unstructured":"Goldstein DJ, Roon KI, Offen WW, Ramadan NM, Phebus LA, Johnson KW, Schaus JM, Ferrari MD (2001b) Selective serotonin 1F (5-HT1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet 358:1230\u20131234","journal-title":"Lancet"},{"key":"322_CR122","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1468-2982.2001.00208.x","volume":"21","author":"B G\u00f3mez-Mancilla","year":"2001","unstructured":"G\u00f3mez-Mancilla B, Cutler NR, Leibowitz MT, Spierings EL, Klapper JA, Diamond S, Goldstein J, Smith T, Couch JR, Fleishaker J, Azie N, Blunt DE (2001) Safety and efficacy of PNU-142633, a selective 5-HT1D agonist, in patients with acute migraine. Cephalalgia 21:727\u2013732","journal-title":"Cephalalgia"},{"key":"322_CR123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lfs.2006.01.003","volume":"79","author":"S Gupta","year":"2006","unstructured":"Gupta S, Mehrotra S, Avezaat CJJ, Villal\u00f3n CM, Saxena PR, MaassenVanDenBrink A (2006a) Characterisation of CGRP receptors in the human isolated middle meningeal artery. Life Sci 79:265\u2013271","journal-title":"Life Sci"},{"key":"322_CR124","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2005.11.020","volume":"530","author":"S Gupta","year":"2006","unstructured":"Gupta S, Mehrotra S, Villal\u00f3n CM, Garrelds IM, de Vries R, van Kats JP, Sharma HS, Saxena PR, MaassenVanDenBrink A (2006b) Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity. Eur J Pharmacol 530:107\u2013116","journal-title":"Eur J Pharmacol"},{"key":"322_CR125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pharmthera.2006.08.009","volume":"113","author":"S Gupta","year":"2007","unstructured":"Gupta S, Mehrotra S, Villal\u00f3n CM, Perusqu\u00eda M, Saxena PR, MaassenVanDenBrink A (2007) Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Ther 113:321\u2013340","journal-title":"Pharmacol Ther"},{"key":"322_CR126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-1838(00)00137-5","volume":"81","author":"SG Hamilton","year":"2000","unstructured":"Hamilton SG, McMahon SB (2000) ATP as a peripheral mediator of pain. J Auton Nerv Syst 81:187\u2013194","journal-title":"J Auton Nerv Syst"},{"key":"322_CR127","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncpneuro0178","volume":"2","author":"MG Hanna","year":"2006","unstructured":"Hanna MG (2006) Genetic neurological channelopathies. Nat Clin Pract Neurol 2:252\u2013263","journal-title":"Nat Clin Pract Neurol"},{"key":"322_CR128","doi-asserted-by":"crossref","first-page":"108S","DOI":"10.1023\/A:1026610418663","volume":"44","author":"WL Hasler","year":"1999","unstructured":"Hasler WL (1999) Serotonin receptor physiology: relation to emesis. Dig Dis Sci 44:108S\u2013113S","journal-title":"Dig Dis Sci"},{"key":"322_CR129","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00001756-199902050-00039","volume":"10","author":"M Hasselblatt","year":"1999","unstructured":"Hasselblatt M, Kohler J, Volles E, Ehrenreich H (1999) Simultaneous monitoring of endothelin-1 and vasopressin plasma levels in migraine. Neuroreport 10:423\u2013425","journal-title":"Neuroreport"},{"key":"322_CR130","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0028-3908(95)00018-2","volume":"34","author":"L Hein","year":"1995","unstructured":"Hein L, Kobilka BK (1995) Adrenergic receptor signal transduction and regulation. Neuropharmacology 34:357\u2013366","journal-title":"Neuropharmacology"},{"key":"322_CR131","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1468-2982.1999.019006589.x","volume":"19","author":"R Hering-Hanit","year":"1999","unstructured":"Hering-Hanit R (1999) Baclofen for prevention of migraine. Cephalalgia 19:589\u2013591","journal-title":"Cephalalgia"},{"key":"322_CR132","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01244454","volume":"83","author":"ML Hern\u00e1ndez","year":"1991","unstructured":"Hern\u00e1ndez ML, Fern\u00e1ndez-Ru\u00edz JJ, de Miguel R, Ramos JA (1991) Time-dependent effects of ovarian steroids on tyrosine hydroxylase activity in the limbic forebrain of female rats. J Neural Transm Gen Sect 83:77\u201384","journal-title":"J Neural Transm Gen Sect"},{"key":"322_CR133","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/030006057800600611","volume":"6","author":"WM Herrmann","year":"1978","unstructured":"Herrmann WM, Kristof M, Sastre M (1978) Preventive treatment of migraine headache with a new isoergolenyl derivative. J Int Med Res 6:476\u2013482","journal-title":"J Int Med Res"},{"key":"322_CR134","first-page":"1","volume":"2","author":"H Heyck","year":"1969","unstructured":"Heyck H (1969) Pathogenesis of migraine. Research clinical studies Headache 2:1\u201328","journal-title":"Research clinical studies Headache"},{"key":"322_CR135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0031-6865(99)00030-8","volume":"74","author":"JP Hieble","year":"2000","unstructured":"Hieble JP (2000) Adrenoceptor subclassification: an approach to improved cardiovascular therapeutics. Pharm Acta Helv 74:163\u2013171","journal-title":"Pharm Acta Helv"},{"key":"322_CR136","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0031-6997(25)06845-0","volume":"47","author":"JP Hieble","year":"1995","unstructured":"Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP, Ruffolo RR Jr (1995) International Union of Pharmacology. X. Recommendation for nomenclature of \u03b11-adrenoceptors: consensus update. Pharmacol Rev 47:267\u2013270","journal-title":"Pharmacol Rev"},{"key":"322_CR137","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(24)01328-0","volume":"49","author":"SJ Hill","year":"1997","unstructured":"Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, Haas HL (1997) International union of pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253\u2013278","journal-title":"Pharmacol Rev"},{"key":"322_CR138","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1212\/01.WNL.0000286940.29755.61","volume":"70","author":"TW Ho","year":"2008","unstructured":"Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM (2008) Randomized controlled trial of an oral CGRP antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304\u20131312","journal-title":"Neurology"},{"key":"322_CR139","volume-title":"Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists","author":"BB Hoffman","year":"2001","unstructured":"Hoffman BB (2001) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists, 10th edn. McGraw-Hill, New York","edition":"10"},{"key":"322_CR140","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00002826-200603000-00005","volume":"29","author":"C Hofmann","year":"2006","unstructured":"Hofmann C, Penner U, Dorow R, Pertz HH, Jahnichen S, Horowski R, Latte KP, Palla D, Schurad B (2006) Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis. Clin Neuropharmacol 29:80\u201386","journal-title":"Clin Neuropharmacol"},{"key":"322_CR141","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1468-2982.2007.01254.x","volume":"27","author":"C Hohoff","year":"2007","unstructured":"Hohoff C, Marziniak M, Lesch KP, Deckert J, Sommer C, Mossner R (2007) An adenosine A2A receptor gene haplotype is associated with migraine with aura. Cephalalgia 27:177\u2013181","journal-title":"Cephalalgia"},{"key":"322_CR142","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1468-2982.2002.00345.x","volume":"22","author":"AC Honey","year":"2002","unstructured":"Honey AC, Bland-Ward PA, Connor HE, Feniuk W, Humphrey PPA (2002) Study of an adenosine A1 receptor agonist on trigeminally evoked dural blood vessel dilation in the anaesthetized rat. Cephalalgia 22:260\u2013264","journal-title":"Cephalalgia"},{"key":"322_CR143","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1526-4610.2006.00438.x","volume":"46","author":"J Honkaniemi","year":"2006","unstructured":"Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S (2006) Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Headache 46:781\u2013787","journal-title":"Headache"},{"key":"322_CR144","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.brainres.2003.11.018","volume":"998","author":"KL Hoskin","year":"2004","unstructured":"Hoskin KL, Lambert GA, Donaldson C, Zagami AS (2004) The 5-hydroxytryptamine1B\/1D\/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Brain Res 998:91\u201399","journal-title":"Brain Res"},{"key":"322_CR145","first-page":"371","volume":"3","author":"D Hoyer","year":"1990","unstructured":"Hoyer D (1990) Serotonin 5-HT3, 5-HT4, and 5-HT-M receptors. Neuropsychopharmacology 3:371\u2013383","journal-title":"Neuropsychopharmacology"},{"key":"322_CR146","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0031-6997(25)06783-3","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157\u2013203","journal-title":"Pharmacol Rev"},{"key":"322_CR147","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2125.1986.tb02932.x","volume":"22","author":"A Hughes","year":"1986","unstructured":"Hughes A, Thom S, Martin G, Redman D, Hasan S, Sever P (1986) The action of a dopamine (DA1) receptor agonist, fenoldopam in human vasculature in vivo and in vitro. Br J Clin Pharmacol 22:535\u2013540","journal-title":"Br J Clin Pharmacol"},{"key":"322_CR148","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/sj.bjp.0701928","volume":"124","author":"PT Hurley","year":"1998","unstructured":"Hurley PT, McMahon RA, Fanning P, O\u2019Boyle KM, Rogers M, Martin F (1998) Functional coupling of a recombinant human 5-HT5A receptor to G-proteins in HEK-293 cells. Br J Pharmacol 124:1238\u20131244","journal-title":"Br J Pharmacol"},{"key":"322_CR149","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1468-2982.2004.00726.x","volume":"24","author":"M Iovino","year":"2004","unstructured":"Iovino M, Feifel U, Yong CL, Wolters JM, Wallenstein G (2004) Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers. Cephalalgia 24:645\u2013656","journal-title":"Cephalalgia"},{"key":"322_CR150","first-page":"51","volume":"44","author":"T Ishida","year":"1998","unstructured":"Ishida T, Kawashima S, Hirata K, Yokoyama M (1998) Nitric oxide is produced via 5-HT1B and 5-HT2B receptor activation in human coronary artery endothelial cells. Kobe J Med Sci 44:51\u201363","journal-title":"Kobe J Med Sci"},{"key":"322_CR151","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0008-6363(98)00162-X","volume":"41","author":"T Ishida","year":"1999","unstructured":"Ishida T, Hirata K, Sakoda T, Kawashima S, Akita H, Yokoyama M (1999) Identification of mRNA for 5-HT1 and 5-HT2 receptor subtypes in human coronary arteries. Cardiovasc Res 41:267\u2013274","journal-title":"Cardiovasc Res"},{"key":"322_CR152","unstructured":"IUPHAR (2006) 3rd Major update to IUPHAR receptor database. http:\/\/www.iuphar-db.org\/GPCR\/ReceptorFamiliesForward ."},{"key":"322_CR153","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/00220345990780010801","volume":"78","author":"DL Jackson","year":"1999","unstructured":"Jackson DL, Hargreaves KM (1999) Activation of excitatory amino acid receptors in bovine dental pulp evokes the release of iCGRP. J Dent Res 78:54\u201360","journal-title":"J Dent Res"},{"key":"322_CR154","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejphar.2003.09.021","volume":"481","author":"I Jansen-Olesen","year":"2003","unstructured":"Jansen-Olesen I, Jorgensen L, Engel U, Edvinsson L (2003) In-depth characterization of CGRP receptors in human intracranial arteries. Eur J Pharmacol 481:207\u2013216","journal-title":"Eur J Pharmacol"},{"key":"322_CR155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/01.WNL.0000172638.58172.5a","volume":"65","author":"JC Jen","year":"2005","unstructured":"Jen JC, Wan J, Palos TP, Howard BD, Baloh RW (2005) Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 65:529\u2013534","journal-title":"Neurology"},{"key":"322_CR156","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1526-4610.1987.hed2707372.x","volume":"27","author":"V Johannsson","year":"1987","unstructured":"Johannsson V, Nilsson LR, Widelius T, Javerfalk T, Hellman P, Akesson JA, Olerud B, Gustafsson CL, Raak A, Sandahl G et al (1987) Atenolol in migraine prophylaxis a double-blind cross-over multicentre study. Headache 27:372\u2013374","journal-title":"Headache"},{"key":"322_CR157","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1468-2982.2003.00464.x","volume":"23","author":"KW Johnson","year":"2003","unstructured":"Johnson KW, Nelson DL, Dieckman DK, Wainscott DB, Lucaites VL, Audia JE, Owton WM, Phebus LA (2003) Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. Cephalalgia 23:117\u2013123","journal-title":"Cephalalgia"},{"key":"322_CR158","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0024-3205(94)00546-X","volume":"54","author":"HO Kalkman","year":"1994","unstructured":"Kalkman HO (1994) Is migraine prophylactic activity caused by 5-HT2B or 5-HT2C receptor blockade. Life Sci 54:641\u2013644","journal-title":"Life Sci"},{"key":"322_CR159","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1468-2982.1998.1806329.x","volume":"18","author":"M Kallela","year":"1998","unstructured":"Kallela M, Farkkila M, Saijonmaa O, Fyhrquist F (1998) Endothelin in migraine patients. Cephalalgia 18:329\u2013332","journal-title":"Cephalalgia"},{"key":"322_CR160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.bjp.0705451","volume":"140","author":"K Kapoor","year":"2003","unstructured":"Kapoor K, Arulmani U, Heiligers JPC, Garrelds IM, Willems EW, Doods H, Villal\u00f3n CM, Saxena PR (2003) Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br J Pharmacol 140:329\u2013338","journal-title":"Br J Pharmacol"},{"key":"322_CR161","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/j.1460-2075.1990.tb08280.x","volume":"9","author":"P Kastner","year":"1990","unstructured":"Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9:1603\u20131614","journal-title":"EMBO J"},{"key":"322_CR162","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.55.1.139","volume":"55","author":"H Kaube","year":"2000","unstructured":"Kaube H, Herzog J, Kaufer T, Dichgans M, Diener HC (2000) Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55:139\u2013141","journal-title":"Neurology"},{"key":"322_CR163","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0165-6147(96)01033-4","volume":"18","author":"AJ Kaumann","year":"1997","unstructured":"Kaumann AJ (1997) Four \u03b2-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol Sci 18:70\u201376","journal-title":"Trends Pharmacol Sci"},{"key":"322_CR164","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1043-2760(01)00377-0","volume":"12","author":"MJ Kelly","year":"2001","unstructured":"Kelly MJ, Levin ER (2001) Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152\u2013156","journal-title":"Trends Endocrinol Metab"},{"key":"322_CR165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1212\/WNL.10.2.107","volume":"10","author":"RW Kimball","year":"1960","unstructured":"Kimball RW, Friedman AP, Vallejo E (1960) Effect of serotonin in migraine patients. Neurology 10:107\u2013111","journal-title":"Neurology"},{"key":"322_CR166","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.2823383","volume":"238","author":"BK Kobilka","year":"1987","unstructured":"Kobilka BK, Matsui H, Kobilka TS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ, Regan JW (1987) Cloning, sequencing, and expression of the gene coding for the human platelet \u03b12-adrenergic receptor. Science 238:650\u2013656","journal-title":"Science"},{"key":"322_CR167","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1526-4610.1992.hed3205229.x","volume":"32","author":"H Kowa","year":"1992","unstructured":"Kowa H, Shimomura T, Takahashi K (1992) Platelet gamma-aminobutyric acid levels in migraine and tension-type headache. Headache 32:229\u2013232","journal-title":"Headache"},{"key":"322_CR168","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/sj.bjp.0704588","volume":"135","author":"KA Krobert","year":"2002","unstructured":"Krobert KA, Levy FO (2002) The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects. Br J Pharmacol 135:1563\u20131571","journal-title":"Br J Pharmacol"},{"key":"322_CR169","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1476-5381.1994.tb14886.x","volume":"111","author":"PP Lakhlani","year":"1994","unstructured":"Lakhlani PP, Amenta F, Napoleone P, Felici L, Eikenburg DC (1994) Pharmacological characterization and anatomical localization of prejunctional beta-adrenoceptors in the rat kidney. Br J Pharmacol 111:1296\u20131308","journal-title":"Br J Pharmacol"},{"key":"322_CR170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00210-004-0935-4","volume":"369","author":"GA Lambert","year":"2004","unstructured":"Lambert GA, Donaldson C, Hoskin KL, Boers PM, Zagami AS (2004) Dilatation induced by 5-HT in the middle meningeal artery of the anaesthetised cat. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 369:591\u2013601","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"322_CR171","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","volume":"76","author":"C Lampl","year":"2005","unstructured":"Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76:1730\u20131732","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"322_CR172","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/214597a0","volume":"214","author":"AM Lands","year":"1967","unstructured":"Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG Jr (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597\u2013598","journal-title":"Nature"},{"key":"322_CR173","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1016\/S0021-9258(18)99248-3","volume":"266","author":"SM Lanier","year":"1991","unstructured":"Lanier SM, Downing S, Duzic E, Homcy CJ (1991) Isolation of rat genomic clones encoding subtypes of the \u03b12-adrenergic receptor. Identification of a unique receptor subtype. J Biol Chem 266:10470\u201310478","journal-title":"J Biol Chem"},{"key":"322_CR174","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/00001756-199507310-00003","volume":"6","author":"LH Lassen","year":"1995","unstructured":"Lassen LH, Thomsen LL, Olesen J (1995) Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport 6:1475\u20131479","journal-title":"Neuroreport"},{"key":"322_CR175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00203773","volume":"49","author":"LH Lassen","year":"1996","unstructured":"Lassen LH, Thomsen LL, Kruuse C, Iversen HK, Olesen J (1996) Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine. Support for the NO-hypothesis of migraine. Eur J Clin Pharmacol 49:335\u2013339","journal-title":"Eur J Clin Pharmacol"},{"key":"322_CR176","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1468-2982.1998.1801027.x","volume":"18","author":"LH Lassen","year":"1998","unstructured":"Lassen LH, Ashina M, Christiansen I, Ulrich V, Grover R, Donaldson J, Olesen J (1998) Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks. Cephalalgia 18:27\u201332","journal-title":"Cephalalgia"},{"key":"322_CR177","first-page":"636","volume":"25","author":"YT Lau","year":"2002","unstructured":"Lau YT (2002) Receptor-dependent and genomic-independent actions of estrogen in vascular protection. Chang Gung Med J 25:636\u2013644","journal-title":"Chang Gung Med J"},{"key":"322_CR178","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/j.1476-5381.1995.tb16388.x","volume":"116","author":"WS Lee","year":"1995","unstructured":"Lee WS, Limmroth V, Ayata C, Cutrer FM, Waeber C, Yu X, Moskowitz MA (1995) Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and trigeminal stimulation. Br J Pharmacol 116:1661\u20131667","journal-title":"Br J Pharmacol"},{"key":"322_CR179","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1526-4610.2005.05181.x","volume":"45","author":"ST Lee","year":"2005","unstructured":"Lee ST, Park JH, Kim M (2005) Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study. Headache 45:1004\u20131011","journal-title":"Headache"},{"key":"322_CR180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01249105","volume":"84","author":"KP Lesch","year":"1991","unstructured":"Lesch KP, Lerer B (1991) The 5-HT receptor-G-protein\u2013effector system complex in depression. I. Effect of glucocorticoids. J Neural Transm Gen Sect 84:3\u201318","journal-title":"J Neural Transm Gen Sect"},{"key":"322_CR181","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1096\/fasebj.2.11.2840317","volume":"2","author":"LE Limbird","year":"1988","unstructured":"Limbird LE (1988) Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. Faseb J 2:2686\u20132695","journal-title":"Faseb J"},{"key":"322_CR182","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.0306-5251.2001.01459.x","volume":"52","author":"V Limmroth","year":"2001","unstructured":"Limmroth V, Michel MC (2001) The prevention of migraine: a critical review with special emphasis on \u03b2-adrenoceptor blockers. Br J Clin Pharmacol 52:237\u2013243","journal-title":"Br J Clin Pharmacol"},{"key":"322_CR183","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646\u2013657","journal-title":"Headache"},{"key":"322_CR184","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-510X(96)00287-0","volume":"146","author":"R Lodi","year":"1997","unstructured":"Lodi R, Kemp GJ, Montagna P, Pierangeli G, Cortelli P, Iotti S, Radda GK, Barbiroli B (1997) Quantitative analysis of skeletal muscle bioenergetics and proton efflux in migraine and cluster headache. J Neurol Sci 146:73\u201380","journal-title":"J Neurol Sci"},{"key":"322_CR185","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1016\/S0021-9258(18)38126-2","volume":"266","author":"JW Lomasney","year":"1991","unstructured":"Lomasney JW, Cotecchia S, Lorenz W, Leung WY, Schwinn DA, Yang-Feng TL, Brownstein M, Lefkowitz RJ, Caron MG (1991) Molecular cloning and expression of the cDNA for the \u03b11A-adrenergic receptor. The gene for which is located on human chromosome 5. J Biol Chem 266:6365\u20136369","journal-title":"J Biol Chem"},{"key":"322_CR186","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.93.8.3455","volume":"93","author":"AE Luebke","year":"1996","unstructured":"Luebke AE, Dahl GP, Roos BA, Dickerson IM (1996) Identification of a protein that confers calcitonin gene-related peptide responsiveness to oocytes by using a cystic fibrosis transmembrane conductance regulator assay. Proc Natl Acad Sci USA 93:3455\u20133460","journal-title":"Proc Natl Acad Sci USA"},{"key":"322_CR187","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/00001756-200106130-00015","volume":"12","author":"QP Ma","year":"2001","unstructured":"Ma QP (2001) Co-localization of 5-HT1B\/1D\/1F receptors and glutamate in trigeminal ganglia in rats. Neuroreport 12:1589\u20131591","journal-title":"Neuroreport"},{"key":"322_CR188","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/01.CIR.98.1.25","volume":"98","author":"A MaassenVanDenBrink","year":"1998","unstructured":"MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR (1998) Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 98:25\u201330","journal-title":"Circulation"},{"key":"322_CR189","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/WNL.55.10.1524","volume":"55","author":"A MaassenVanDenBrink","year":"2000","unstructured":"MaassenVanDenBrink A, van den Broek RWM, de Vries R, Bogers AJC, Avezaat CJJ, Saxena PR (2000) Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology 55:1524\u20131530","journal-title":"Neurology"},{"key":"322_CR190","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1258\/136218006778234048","volume":"12","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA (2006) Migraine and the menopause. J Br Menopause Soc 12:104\u2013108","journal-title":"J Br Menopause Soc"},{"key":"322_CR191","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1783\/147118902101195974","volume":"28","author":"EA MacGregor","year":"2002","unstructured":"MacGregor EA, Hackshaw A (2002) Prevention of migraine in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements. J Fam Plann Reprod Health Care 28:27\u201331","journal-title":"J Fam Plann Reprod Health Care"},{"key":"322_CR192","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1212\/01.wnl.0000249114.52802.55","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006a) Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study. Neurology 67:2159\u20132163","journal-title":"Neurology"},{"key":"322_CR193","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1212\/01.wnl.0000233888.18228.19","volume":"67","author":"EA MacGregor","year":"2006","unstructured":"MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A (2006b) Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 67:2154\u20132158","journal-title":"Neurology"},{"key":"322_CR194","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.46.11.1044","volume":"46","author":"AL Magos","year":"1983","unstructured":"Magos AL, Zilkha KJ, Studd JW (1983) Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry 46:1044\u20131046","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"322_CR195","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd1522","volume":"3","author":"F Marceau","year":"2004","unstructured":"Marceau F, Regoli D (2004) Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3:845\u2013852","journal-title":"Nat Rev Drug Discov"},{"key":"322_CR196","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1526-4610.2006.00309.x","volume":"46","author":"VT Martin","year":"2006","unstructured":"Martin VT, Behbehani M (2006) Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis\u2014part I. Headache 46:3\u201323","journal-title":"Headache"},{"key":"322_CR197","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1468-2982.1993.1302089.x","volume":"13","author":"F Mart\u00ednez","year":"1993","unstructured":"Mart\u00ednez F, Castillo J, Rodr\u00edguez JR, Leira R, Noya M (1993) Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 13:89\u201393","journal-title":"Cephalalgia"},{"key":"322_CR198","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1526-4610.2000.00125.x","volume":"40","author":"NT Mathew","year":"2000","unstructured":"Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P (2000) Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache 40:720\u2013723","journal-title":"Headache"},{"key":"322_CR199","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(92)90798-9","volume":"224","author":"T Matsubara","year":"1992","unstructured":"Matsubara T, Moskowitz MA, Huang Z (1992) UK-14,304, R(\u2212)-alpha-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms. Eur J Pharmacol 224:145\u2013150","journal-title":"Eur J Pharmacol"},{"key":"322_CR200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00041444-200103000-00010","volume":"11","author":"S Maude","year":"2001","unstructured":"Maude S, Curtin J, Breen G, Collier D, Russell G, Shaw D, Clair DS (2001) The \u2212141C Ins\/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson\u2019s disease. Psychiatr Genet 11:49\u201352","journal-title":"Psychiatr Genet"},{"key":"322_CR201","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0304-3959(96)03137-5","volume":"67","author":"A May","year":"1996","unstructured":"May A, Gijsman HJ, Wallnofer A, Jones R, Diener HC, Ferrari MD (1996) Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain 67:375\u2013378","journal-title":"Pain"},{"issue":"Pt 7","key":"322_CR202","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/brain\/121.7.1231","volume":"121","author":"A May","year":"1998","unstructured":"May A, Shepheard SL, Knorr M, Effert R, Wessing A, Hargreaves RJ, Goadsby PJ, Diener HC (1998) Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine. Brain 121(Pt 7):1231\u20131237","journal-title":"Brain"},{"key":"322_CR203","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/00004647-200110000-00005","volume":"21","author":"A May","year":"2001","unstructured":"May A, Buchel C, Turner R, Goadsby PJ (2001) Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation. J Cereb Blood Flow Metab 21:1171\u20131176","journal-title":"J Cereb Blood Flow Metab"},{"key":"322_CR204","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1468-2982.2002.00459.x","volume":"22","author":"RB McCall","year":"2002","unstructured":"McCall RB, Huff R, Chio CL, TenBrink R, Bergh CL, Ennis MD, Ghazal NB, Hoffman RL, Meisheri K, Higdon NR, Hall E (2002) Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633. Cephalalgia 22:799\u2013806","journal-title":"Cephalalgia"},{"key":"322_CR205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/30666","volume":"393","author":"LM McLatchie","year":"1998","unstructured":"McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333\u2013339","journal-title":"Nature"},{"key":"322_CR206","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-328X(01)00095-X","volume":"90","author":"AD Medhurst","year":"2001","unstructured":"Medhurst AD, Lezoualc, h F, Fischmeister R, Middlemiss DN, Sanger GJ (2001) Quantitative mRNA analysis of five C-terminal splice variants of the human 5-HT4 receptor in the central nervous system by TaqMan real time RT-PCR. Brain Res Mol Brain Res 90:125\u2013134","journal-title":"Brain Res Mol Brain Res"},{"key":"322_CR207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00210-006-0108-8","volume":"374","author":"S Mehrotra","year":"2006","unstructured":"Mehrotra S, Gupta S, Garrelds IM, Villal\u00f3n CM, Saxena PR, Bogers AJJC, MaassenVanDenBrink A (2006) Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 374:163\u2013175","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"322_CR208","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1526-4610.2006.00530.x","volume":"47","author":"S Mehrotra","year":"2007","unstructured":"Mehrotra S, Gupta S, Villal\u00f3n CM, Boomsma F, Saxena PR, MaassenVanDenBrink A (2007) Rat carotid artery responses to \u03b1-adrenergic receptor agonists and 5-HT after ovariectomy and hormone replacement. Headache 47:236\u2013246","journal-title":"Headache"},{"key":"322_CR209","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1476-5381.1989.tb14618.x","volume":"98","author":"AD Michel","year":"1989","unstructured":"Michel AD, Loury DN, Whiting RL (1989) Differences between the \u03b12-adrenoceptor in rat submaxillary gland and the \u03b12A- and \u03b12B-adrenoceptor subtypes. Br J Pharmacol 98:890\u2013897","journal-title":"Br J Pharmacol"},{"key":"322_CR210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0163-7258(00)00092-9","volume":"88","author":"GA Michelotti","year":"2000","unstructured":"Michelotti GA, Price DT, Schwinn DA (2000) \u03b11-adrenergic receptor regulation: basic science and clinical implications. Pharmacol Ther 88:281\u2013309","journal-title":"Pharmacol Ther"},{"key":"322_CR211","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1526-4610.2003.03074.x","volume":"43","author":"RO Mill\u00e1n-Guerrero","year":"2003","unstructured":"Mill\u00e1n-Guerrero RO, Pineda-Lucatero AG, Hern\u00e1ndez-Benjamin T, Tene CE, Pacheco MF (2003) N-alpha-methylhistamine safety and efficacy in migraine prophylaxis: phase I and phase II studies. Headache 43:389\u2013394","journal-title":"Headache"},{"key":"322_CR212","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1017\/S0317167100004960","volume":"33","author":"RO Mill\u00e1n-Guerrero","year":"2006","unstructured":"Mill\u00e1n-Guerrero RO, Isais-Mill\u00e1n R, Benjamin TH, Tene CE (2006) N-alpha-methyl histamine safety and efficacy in migraine prophylaxis: phase III study. Can J Neurol Sci 33:195\u2013199","journal-title":"Can J Neurol Sci"},{"key":"322_CR213","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1517\/14656566.1.3.391","volume":"1","author":"DS Millson","year":"2000","unstructured":"Millson DS, Tepper SJ, Rapoport AM (2000) Migraine pharmacotherapy with oral triptans: a rational approach to clinical management. Expert Opin Pharmacother 1:391\u2013404","journal-title":"Expert Opin Pharmacother"},{"key":"322_CR214","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0304-3959(98)00051-7","volume":"76","author":"DD Mitsikostas","year":"1998","unstructured":"Mitsikostas DD, Sanchez del Rio M, Waeber C, Moskowitz MA, Cutrer FM (1998) The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis. Pain 76:239\u2013248","journal-title":"Pain"},{"key":"322_CR215","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjp.0702584","volume":"127","author":"DD Mitsikostas","year":"1999","unstructured":"Mitsikostas DD, Sanchez del Rio M, Waeber C, Huang Z, Cutrer FM, Moskowitz MA (1999) Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis. Br J Pharmacol 127:623\u2013630","journal-title":"Br J Pharmacol"},{"key":"322_CR216","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s100720300005","volume":"23","author":"M Mochi","year":"2003","unstructured":"Mochi M, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Scapoli C, Montagna P (2003) A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes. Neurol Sci 23:301\u2013305","journal-title":"Neurol Sci"},{"key":"322_CR217","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1152\/jn.1987.57.3.869","volume":"57","author":"I Mody","year":"1987","unstructured":"Mody I, Lambert JD, Heinemann U (1987) Low extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices. J Neurophysiol 57:869\u2013888","journal-title":"J Neurophysiol"},{"key":"322_CR218","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1254\/jphs.SRJ05001X","volume":"99","author":"ME Moreau","year":"2005","unstructured":"Moreau ME, Garbacki N, Molinaro G, Brown NJ, Marceau F, Adam A (2005) The kallikrein\u2013kinin system: current and future pharmacological targets. J Pharmacol Sci 99:6\u201338","journal-title":"J Pharmacol Sci"},{"key":"322_CR219","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.me.44.020193.001045","volume":"44","author":"MA Moskowitz","year":"1993","unstructured":"Moskowitz MA, Cutrer FM (1993) Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med 44:145\u2013154","journal-title":"Annu Rev Med"},{"key":"322_CR220","first-page":"181","volume":"145","author":"MA Moskowitz","year":"1989","unstructured":"Moskowitz MA, Buzzi MG, Sakas DE, Linnik MD (1989) Pain mechanisms underlying vascular headaches. Progress Report 1989. Rev Neurol 145:181\u2013193","journal-title":"Rev Neurol"},{"key":"322_CR221","first-page":"571","volume":"244","author":"TJ Murphy","year":"1988","unstructured":"Murphy TJ, Bylund DB (1988) Characterization of \u03b12\u2013adrenergic receptors in the OK cell, an opossum kidney cell line. J Pharmacol Exp Ther 244:571\u2013578","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR222","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.neuroscience.2006.07.012","volume":"142","author":"S Nag","year":"2006","unstructured":"Nag S, Mokha SS (2006) Activation of \u03b12-adrenoceptors in the trigeminal region produces sex-specific modulation of nociception in the rat. Neuroscience 142:1255\u20131262","journal-title":"Neuroscience"},{"key":"322_CR223","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1212\/WNL.44.12_Suppl_10.S6","volume":"44","author":"J Olesen","year":"1994","unstructured":"Olesen J, Lipton RB (1994) Migraine classification and diagnosis. International Headache Society criteria. Neurology 44:S6\u201310","journal-title":"Neurology"},{"key":"322_CR224","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","volume":"350","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine. N Engl J Med 350:1104\u20131110","journal-title":"N Engl J Med"},{"key":"322_CR225","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00004647-200205000-00014","volume":"22","author":"KR Oliver","year":"2002","unstructured":"Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG (2002) Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 22:620\u2013629","journal-title":"J Cereb Blood Flow Metab"},{"key":"322_CR226","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","volume":"87","author":"RA Ophoff","year":"1996","unstructured":"Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543\u2013552","journal-title":"Cell"},{"key":"322_CR227","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1152\/ajpregu.00338.2003","volume":"286","author":"JM Orshal","year":"2004","unstructured":"Orshal JM, Khalil RA (2004) Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286:R233\u2013249","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"322_CR228","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1476-5381.1991.tb12533.x","volume":"104","author":"M Oshita","year":"1991","unstructured":"Oshita M, Kigoshi S, Muramatsu I (1991) Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex. Br J Pharmacol 104:961\u2013965","journal-title":"Br J Pharmacol"},{"key":"322_CR229","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1152\/physrev.1954.34.3.563","volume":"34","author":"IH Page","year":"1954","unstructured":"Page IH (1954) Serotonin (5 Hydroxytryptamine). Physiol Rev 34:563\u2013588","journal-title":"Physiol Rev"},{"key":"322_CR230","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1468-2982.2000.00075.x","volume":"20","author":"JE Palmer","year":"2000","unstructured":"Palmer JE, Chronicle EP, Rolan P, Mulleners WM (2000) Cortical hyperexcitability is cortical under-inhibition: evidence from a novel functional test of migraine patients. Cephalalgia 20:525\u2013532","journal-title":"Cephalalgia"},{"key":"322_CR231","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000008151","volume":"43","author":"S Paterna","year":"2000","unstructured":"Paterna S, Di Pasquale P, D, Angelo A, Seidita G, Tuttolomondo A, Cardinale A, Maniscalchi T, Follone G, Giubilato A, Tarantello M, Licata G (2000) Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 43:133\u2013136","journal-title":"Eur Neurol"},{"key":"322_CR232","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1124\/jpet.106.117101","volume":"312","author":"M Peeters","year":"2007","unstructured":"Peeters M, Gunthorpe MJ, Strijbos PJ, Goldsmith P, Upton N, James MF (2007) Effects of pan- and subtype-selective NMDA receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine. J Pharmacol Exp Ther 312:564\u2013572","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR233","first-page":"876","volume":"40","author":"DM P\u00e9rez","year":"1991","unstructured":"P\u00e9rez DM, Piascik MT, Graham RM (1991) Solution-phase library screening for the identification of rare clones: isolation of an \u03b11D-adrenergic receptor cDNA. Mol Pharmacol 40:876\u2013883","journal-title":"Mol Pharmacol"},{"key":"322_CR234","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/ana.410230512","volume":"23","author":"SJ Peroutka","year":"1988","unstructured":"Peroutka SJ (1988) Antimigraine drug interactions with serotonin receptor subtypes in human brain. Ann Neurol 23:500\u2013504","journal-title":"Ann Neurol"},{"key":"322_CR235","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.49.3.650","volume":"49","author":"SJ Peroutka","year":"1997","unstructured":"Peroutka SJ (1997) Dopamine and migraine. Neurology 49:650\u2013656","journal-title":"Neurology"},{"key":"322_CR236","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1526-4610.2004.04011.x","volume":"44","author":"SJ Peroutka","year":"2004","unstructured":"Peroutka SJ (2004) Migraine: a chronic sympathetic nervous system disorder. Headache 44:53\u201364","journal-title":"Headache"},{"key":"322_CR237","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/mi.5.5.10","volume":"5","author":"SJ Peroutka","year":"2005","unstructured":"Peroutka SJ (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5:304\u2013311","journal-title":"Mol Interv"},{"key":"322_CR238","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.49.1.201","volume":"49","author":"SJ Peroutka","year":"1997","unstructured":"Peroutka SJ, Wilhoit T, Jones K (1997) Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) NcoI alleles. Neurology 49:201\u2013206","journal-title":"Neurology"},{"key":"322_CR239","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF03401725","volume":"4","author":"SJ Peroutka","year":"1998","unstructured":"Peroutka SJ, Price SC, Wilhoit TL, Jones KW (1998) Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 4:14\u201321","journal-title":"Mol Med"},{"key":"322_CR240","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1468-2982.2005.00869.x","volume":"25","author":"KA Petersen","year":"2005","unstructured":"Petersen KA, Nilsson E, Olesen J, Edvinsson L (2005a) Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo. Cephalalgia 25:424\u2013432","journal-title":"Cephalalgia"},{"key":"322_CR241","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.clpt.2004.10.001","volume":"77","author":"KA Petersen","year":"2005","unstructured":"Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J (2005b) BIBN4096BS antagonizes human \u03b1-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77:202\u2013213","journal-title":"Clin Pharmacol Ther"},{"key":"322_CR242","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0024-3205(97)00885-0","volume":"61","author":"LA Phebus","year":"1997","unstructured":"Phebus LA, Johnson KW, Zgombick JM, Gilbert PJ, Van Belle K, Mancuso V, Nelson DL, Calligaro DO, Kiefer AD Jr, Branchek TA, Flaugh ME (1997) Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine. Life Sci 61:2117\u20132126","journal-title":"Life Sci"},{"key":"322_CR243","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0022-3565(24)37045-4","volume":"283","author":"MT Piascik","year":"1997","unstructured":"Piascik MT, Hrometz SL, Edelmann SE, Guarino RD, Hadley RW, Brown RD (1997) Immunocytochemical localization of the \u03b11B-adrenergic receptor and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J Pharmacol Exp Ther 283:854\u2013868","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR244","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/mol.61.1.85","volume":"61","author":"A Pindon","year":"2002","unstructured":"Pindon A, van Hecke G, van Gompel P, Lesage AS, Leysen JE, Jurzak M (2002) Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Gas- and Gai\/o-proteins. Mol Pharmacol 61:85\u201396","journal-title":"Mol Pharmacol"},{"key":"322_CR245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1527-3458.2002.tb00217.x","volume":"8","author":"B Pouzet","year":"2002","unstructured":"Pouzet B (2002) SB-258741: a 5-HT7 receptor antagonist of potential clinical interest. CNS Drug Rev 8:90\u2013100","journal-title":"CNS Drug Rev"},{"key":"322_CR246","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjp.0703655","volume":"131","author":"KJ Powell","year":"2000","unstructured":"Powell KJ, Ma W, Sutak M, Doods H, Quirion R, Jhamandas K (2000) Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol 131:875\u2013884","journal-title":"Br J Pharmacol"},{"key":"322_CR247","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","volume":"54","author":"DR Poyner","year":"2002","unstructured":"Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM (2002) International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233\u2013246","journal-title":"Pharmacol Rev"},{"key":"322_CR248","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/PL00005056","volume":"356","author":"GW Price","year":"1997","unstructured":"Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Gothert M, Jones BJ, Roberts C, Watson JM, Middlemiss DN (1997) SB-216641 and BRL-15572-compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 356:312\u2013320","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"322_CR249","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0047-6374(01)00358-X","volume":"123","author":"M Quartu","year":"2002","unstructured":"Quartu M, Serra MP, Ambu R, Lai ML, Del Fiacco M (2002) AMPA-type glutamate receptor subunits 2\/3 in the human trigeminal sensory ganglion and subnucleus caudalis from prenatal ages to adulthood. Mech Ageing Dev 123:463\u2013471","journal-title":"Mech Ageing Dev"},{"key":"322_CR250","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.1992.tb22759.x","volume":"657","author":"R Quirion","year":"1992","unstructured":"Quirion R, Van Rossum D, Dumont Y, St-Pierre S, Fournier A (1992) Characterization of CGRP1 and CGRP2 receptor subtypes. Ann N Y Acad Sci 657:88\u2013105","journal-title":"Ann N Y Acad Sci"},{"key":"322_CR251","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0002-9149(66)90056-7","volume":"18","author":"R Rabkin","year":"1966","unstructured":"Rabkin R, Stables DP, Levin NW, Suzman MM (1966) The prophylactic value of propranolol in angina pectoris. Am J Cardiol 18:370\u2013383","journal-title":"Am J Cardiol"},{"key":"322_CR252","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1526-4610.1989.hed2909590.x","volume":"29","author":"NM Ramadan","year":"1989","unstructured":"Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KMA (1989) Low brain magnesium in migraine. Headache 29:590\u2013593","journal-title":"Headache"},{"key":"322_CR253","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1468-2982.1997.1702073.x","volume":"17","author":"NM Ramadan","year":"1997","unstructured":"Ramadan NM, Schultz LL, Gilkey SJ (1997) Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 17:73\u201380","journal-title":"Cephalalgia"},{"key":"322_CR254","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1468-2982.2003.00525.x","volume":"23","author":"NM Ramadan","year":"2003","unstructured":"Ramadan NM, Skljarevski V, Phebus LA, Johnson KW (2003) 5-HT1F receptor agonists in acute migraine treatment: a hypothesis. Cephalalgia 23:776\u2013785","journal-title":"Cephalalgia"},{"key":"322_CR255","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0021-9258(18)57137-4","volume":"176","author":"MM Rapport","year":"1948","unstructured":"Rapport MM, Green AA, Page IH (1948) Serum vasoconstrictor (serotonin). IV. Isolation and characterization. J Biol Chem 176:1243\u20131251","journal-title":"J Biol Chem"},{"key":"322_CR256","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0895-4356(91)90147-2","volume":"44","author":"BK Rasmussen","year":"1991","unstructured":"Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population\u2014a prevalence study. J Clin Epidemiol 44:1147\u20131157","journal-title":"J Clin Epidemiol"},{"key":"322_CR257","doi-asserted-by":"crossref","first-page":"6301","DOI":"10.1073\/pnas.85.17.6301","volume":"85","author":"JW Regan","year":"1988","unstructured":"Regan JW, Kobilka TS, Yang-Feng TL, Caron MG, Lefkowitz RJ, Kobilka BK (1988) Cloning and expression of a human kidney cDNA for an \u03b12-adrenergic receptor subtype. Proc Natl Acad Sci USA 85:6301\u20136305","journal-title":"Proc Natl Acad Sci USA"},{"key":"322_CR258","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1526-4610.2001.041007733.x","volume":"41","author":"P Roffey","year":"2001","unstructured":"Roffey P, Mikhail M, Thangathurai D (2001) NMDA receptor blockade prevents nitroglycerin-induced headaches. Headache 41:733","journal-title":"Headache"},{"key":"322_CR259","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/1531-8249(200002)47:2<238::AID-ANA15>3.0.CO;2-L","volume":"47","author":"KI Roon","year":"2000","unstructured":"Roon KI, Olesen J, Diener HC, Ellis P, Hettiarachchi J, Poole PH, Christianssen I, Kleinermans D, Kok JG, Ferrari MD (2000) No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials. Ann Neurol 47:238\u2013241","journal-title":"Ann Neurol"},{"key":"322_CR260","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0022-3565(24)36743-6","volume":"281","author":"A Rouleau","year":"1997","unstructured":"Rouleau A, Garbarg M, Ligneau X, Mantion C, Lavie P, Advenier C, Lecomte JM, Krause M, Stark H, Schunack W, Schwartz JC (1997) Bioavailability, antinociceptive and antiinflammatory properties of BP 2\u201394, a histamine H3 receptor agonist prodrug. J Pharmacol Exp Ther 281:1085\u20131094","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR261","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1523\/JNEUROSCI.17-17-06611.1997","volume":"17","author":"Y Sahara","year":"1997","unstructured":"Sahara Y, Noro N, Iida Y, Soma K, Nakamura Y (1997) Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons. J Neurosci 17:6611\u20136620","journal-title":"J Neurosci"},{"key":"322_CR262","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.107.130344","volume":"324","author":"CA Salvatore","year":"2008","unstructured":"Salvatore CA, Hershey JC, Corcoran HA, Fay JF, Johnston VK, Moore EL, Mosser SD, Burgey CS, Paone DV, Shaw AW, Graham SL, Vacca JP, Williams TM, Koblan KS, Kane SA (2008) Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3- yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carbox amide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine. J Pharmacol Exp Ther 324:416\u2013421","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR263","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-2982.2004.00723.x","volume":"24","author":"CN Sang","year":"2004","unstructured":"Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Johnson KW, Phebus LA, Bleakman D, Ornstein PL, Arnold B, Tepper SJ, Vandenhende F (2004) LY293558, a novel AMPA\/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia 24:596\u2013602","journal-title":"Cephalalgia"},{"key":"322_CR264","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-2982.1992.1201021.x","volume":"12","author":"P Sarchielli","year":"1992","unstructured":"Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V (1992) Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients. Cephalalgia 12:21\u201327","journal-title":"Cephalalgia"},{"key":"322_CR265","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1468-2982.1999.1909810.x","volume":"19","author":"P Sarchielli","year":"1999","unstructured":"Sarchielli P, Alberti A, Russo S, Codini M, Panico R, Floridi A, Gallai V (1999) Nitric oxide pathway, Ca2+, and serotonin content in platelets from patients suffering from chronic daily headache. Cephalalgia 19:810\u2013816","journal-title":"Cephalalgia"},{"key":"322_CR266","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.bjp.0701609","volume":"123","author":"D Sarsero","year":"1998","unstructured":"Sarsero D, Molenaar P, Kaumann AJ (1998) Validity of (\u2212)-[3H]-CGP 12177A as a radioligand for the \u2018putative \u03b24-adrenoceptor\u2019 in rat atrium. Br J Pharmacol 123:371\u2013380","journal-title":"Br J Pharmacol"},{"issue":"Suppl 7","key":"322_CR267","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00005344-199001001-00004","volume":"15","author":"PR Saxena","year":"1990","unstructured":"Saxena PR, Villal\u00f3n CM (1990) Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 15(Suppl 7):S17\u2013S34","journal-title":"J Cardiovasc Pharmacol"},{"key":"322_CR268","first-page":"411","volume-title":"The headaches","author":"PR Saxena","year":"2006","unstructured":"Saxena PR, Tfelt-Hansen P (2006) Triptans, 5-HT1B\/1D receptor agonists in the acute treatment of migraines. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches. Lippincott Williams & Wilkins, Philadelphia, pp 411\u201338"},{"key":"322_CR269","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(92)90014-U","volume":"220","author":"PR Saxena","year":"1992","unstructured":"Saxena PR, Heiligers JPC, Villal\u00f3n CM, Ferrari MD (1992) Effects of tertatolol, a \u00df-adrenoceptor antagonist with agonist affinity at 5-HT1A receptors, in an animal model of migraine: comparison with propranolol and pindolol. Eur J Pharmacol 220:79\u201386","journal-title":"Eur J Pharmacol"},{"key":"322_CR270","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0165-6147(98)01228-0","volume":"19","author":"PR Saxena","year":"1998","unstructured":"Saxena PR, De Vries P, Villal\u00f3n CM (1998) 5-HT1-like receptors: a time to bid goodbye. Trends Pharmacol Sci 19:311\u2013316","journal-title":"Trends Pharmacol Sci"},{"key":"322_CR271","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.bjp.0705437","volume":"140","author":"B Schaerlinger","year":"2003","unstructured":"Schaerlinger B, Hickel P, Etienne N, Guesnier L, Maroteaux L (2003) Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy. Br J Pharmacol 140:277\u2013284","journal-title":"Br J Pharmacol"},{"key":"322_CR272","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1460-9568.1996.tb01583.x","volume":"8","author":"K Schmuck","year":"1996","unstructured":"Schmuck K, Ullmer C, Kalkman HO, Probst A, Lubbert H (1996) Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache. Eur J Neurosci 8:959\u2013967","journal-title":"Eur J Neurosci"},{"key":"322_CR273","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.322.7277.19","volume":"322","author":"H Schrader","year":"2001","unstructured":"Schrader H, Stovner LJ, Helde G, Sand T, Bovim G (2001) Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. Brit Med J 322:19\u201322","journal-title":"Brit Med J"},{"key":"322_CR274","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1526-4610.2006.00413.x","volume":"46","author":"V Shaygannejad","year":"2006","unstructured":"Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V (2006) Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study. Headache 46:642\u2013648","journal-title":"Headache"},{"key":"322_CR275","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1468-2982.1999.1910851.x","volume":"19","author":"S Shepheard","year":"1999","unstructured":"Shepheard S, Edvinsson L, Cumberbatch M, Williamson D, Mason G, Webb J, Boyce S, Hill RG, Hargreaves RJ (1999) Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370. Cephalalgia 19:851\u2013858","journal-title":"Cephalalgia"},{"key":"322_CR276","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0091-3057(91)90125-L","volume":"40","author":"JC Shih","year":"1991","unstructured":"Shih JC, Yang W, Chen K, Gallaher T (1991) Molecular biology of serotonin 5-HT receptors. Pharmacol Biochem Behav 40:1053\u20131058","journal-title":"Pharmacol Biochem Behav"},{"key":"322_CR277","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1468-2982.1998.1807421.x","volume":"18","author":"SD Silberstein","year":"1998","unstructured":"Silberstein SD (1998) Methysergide. Cephalalgia 18:421\u2013435","journal-title":"Cephalalgia"},{"issue":"Suppl 4","key":"322_CR278","first-page":"4S30","volume":"156","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD (2000) Sex hormones and headache. Rev Neurol 156(Suppl 4):4S30\u20134S41","journal-title":"Rev Neurol"},{"key":"322_CR279","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.61.4.490","volume":"61","author":"SD Silberstein","year":"2004","unstructured":"Silberstein SD, Neto W, Schmitt J, Jacobs D (2004) Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 61:490\u2013495","journal-title":"Arch Neurol"},{"key":"322_CR280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-8981(02)00301-7","volume":"326","author":"AP Silva","year":"2002","unstructured":"Silva AP, Cavadas C, Grouzmann E (2002) Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326:3\u201325","journal-title":"Clin Chim Acta"},{"key":"322_CR281","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0026-895X(25)12920-9","volume":"40","author":"V Simonneaux","year":"1991","unstructured":"Simonneaux V, Ebadi M, Bylund DB (1991) Identification and characterization of \u03b12D-adrenergic receptors in bovine pineal gland. Mol Pharmacol 40:235\u2013241","journal-title":"Mol Pharmacol"},{"key":"322_CR282","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1476-5381.1990.tb15798.x","volume":"100","author":"GW Smith","year":"1990","unstructured":"Smith GW, Farmer JB, Ince F, Matu K, Mitchell PD, Naya I, Springthorpe B (1990) FPL 63012AR: a potent D1-receptor agonist. Br J Pharmacol 100:295\u2013300","journal-title":"Br J Pharmacol"},{"key":"322_CR283","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/sj.npp.1300510","volume":"29","author":"LJ Smith","year":"2004","unstructured":"Smith LJ, Henderson JA, Abell CW, Bethea CL (2004) Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 29:2035\u20132045","journal-title":"Neuropsychopharmacology"},{"key":"322_CR284","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.25.3.245","volume":"25","author":"BW Somerville","year":"1975","unstructured":"Somerville BW (1975) Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration. Neurology 25:245\u2013250","journal-title":"Neurology"},{"key":"322_CR285","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1526-4610.1978.hed1802075.x","volume":"18","author":"BW Somerville","year":"1978","unstructured":"Somerville BW, Herrmann WM (1978) Migraine prophylaxis with lisuride hydrogen maleate\u2014a double blind study of Lisuride versus placebo. Headache 18:75\u201379","journal-title":"Headache"},{"key":"322_CR286","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1124\/pr.54.2.231","volume":"54","author":"M Spedding","year":"2002","unstructured":"Spedding M, Bonner TI, Watson SP (2002) International Union of Pharmacology. XXXI. Recommendations for the nomenclature of multimeric G protein-coupled receptors. Pharmacol Rev 54:231\u2013232","journal-title":"Pharmacol Rev"},{"key":"322_CR287","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1046\/j.1526-4610.2002.02142.x","volume":"42","author":"A Srikiatkhachorn","year":"2002","unstructured":"Srikiatkhachorn A, Suwattanasophon C, Ruangpattanatawee U, Phansuwan-Pujito P (2002) 5-HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks. Headache 42:566\u2013574","journal-title":"Headache"},{"key":"322_CR288","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/jama.1984.03350180030025","volume":"252","author":"S Stellar","year":"1984","unstructured":"Stellar S, Ahrens SP, Meibohm AR, Reines SA (1984) Migraine prevention with timolol. A double-blind crossover study. JAMA 252:2576\u20132580","journal-title":"JAMA"},{"key":"322_CR289","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.1992.03480010072027","volume":"267","author":"WF Stewart","year":"1992","unstructured":"Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267:64\u201369","journal-title":"JAMA"},{"key":"322_CR290","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1152\/physrev.1984.64.2.661","volume":"64","author":"GL Stiles","year":"1984","unstructured":"Stiles GL, Caron MG, Lefkowitz RJ (1984) \u03b2-adrenergic receptors: biochemical mechanisms of physiological regulation. Physiol Rev 64:661\u2013743","journal-title":"Physiol Rev"},{"key":"322_CR291","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0306-4522(98)00536-3","volume":"90","author":"RJ Storer","year":"1999","unstructured":"Storer RJ, Goadsby PJ (1999) Trigeminovascular nociceptive transmission involves N-methyl-d-aspartate and non-N-methyl-d-aspartate glutamate receptors. Neuroscience 90:1371\u20131376","journal-title":"Neuroscience"},{"key":"322_CR292","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.bjp.0705807","volume":"142","author":"RJ Storer","year":"2004","unstructured":"Storer RJ, Akerman S, Goadsby PJ (2004a) Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 142:1171\u20131181","journal-title":"Br J Pharmacol"},{"key":"322_CR293","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.brainres.2004.03.068","volume":"1013","author":"RJ Storer","year":"2004","unstructured":"Storer RJ, Akerman S, Shields KG, Goadsby PJ (2004b) GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil. Brain Res 1013:188\u2013193","journal-title":"Brain Res"},{"key":"322_CR294","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1526-4610.1987.hed2708421.x","volume":"27","author":"A Sudilovsky","year":"1987","unstructured":"Sudilovsky A, Elkind AH, Ryan RE Sr, Saper JR, Stern MA, Meyer JH (1987) Comparative efficacy of nadolol and propranolol in the management of migraine. Headache 27:421\u2013426","journal-title":"Headache"},{"key":"322_CR295","first-page":"1154","volume":"264","author":"T Takenaka","year":"1993","unstructured":"Takenaka T, Forster H, Epstein M (1993) Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435. J Pharmacol Exp Ther 264:1154\u20131159","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR296","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-3940(92)90339-9","volume":"141","author":"SJ Tallaksen-Greene","year":"1992","unstructured":"Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ (1992) Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett 141:79\u201383","journal-title":"Neurosci Lett"},{"key":"322_CR297","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1043-2760(03)00026-2","volume":"14","author":"A Tanoue","year":"2003","unstructured":"Tanoue A, Koshimizu TA, Shibata K, Nasa Y, Takeo S, Tsujimoto G (2003) Insights into \u03b11-adrenoceptor function in health and disease from transgenic animal studies. Trends Endocrinol Metab 14:107\u2013113","journal-title":"Trends Endocrinol Metab"},{"key":"322_CR298","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0025-7125(05)70353-9","volume":"85","author":"SJ Tepper","year":"2001","unstructured":"Tepper SJ (2001) Safety and rational use of the triptans. Med Clin North Am 85:959\u2013970","journal-title":"Med Clin North Am"},{"key":"322_CR299","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(01)01617-2","volume":"302","author":"JA Terr\u00f3n","year":"2001","unstructured":"Terr\u00f3n JA, Bouchelet I, Hamel E (2001) 5-HT7 receptor mRNA expression in human trigeminal ganglia. Neurosci Lett 302:9\u201312","journal-title":"Neurosci Lett"},{"key":"322_CR300","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.56.8.1028","volume":"56","author":"GM Terwindt","year":"2001","unstructured":"Terwindt GM, Ophoff RA, van Eijk R, Vergouwe MN, Haan J, Frants RR, Sandkuijl LA, Ferrari MD (2001) Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 56:1028\u20131032","journal-title":"Neurology"},{"key":"322_CR301","first-page":"519","volume-title":"The headaches","author":"P Tfelt-Hansen","year":"2006","unstructured":"Tfelt-Hansen P, Rolan P (2006) \u03b2-Adrenoceptor blocking drugs in migraine prophylaxis. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches. Lippincott Williams & Wilkins, Philadelphia, pp 519\u2013528"},{"key":"322_CR302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1984.tb07772.x","volume":"69","author":"P Tfelt-Hansen","year":"1984","unstructured":"Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J (1984) Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 69:1\u20138","journal-title":"Acta Neurol Scand"},{"key":"322_CR303","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.pharmthera.2005.12.006","volume":"111","author":"DR Thomas","year":"2006","unstructured":"Thomas DR (2006) 5-ht5A receptors as a therapeutic target. Pharmacol Ther 111:707\u2013714","journal-title":"Pharmacol Ther"},{"key":"322_CR304","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1568007043482633","volume":"3","author":"DR Thomas","year":"2004","unstructured":"Thomas DR, Hagan JJ (2004) 5-HT7 receptors. Curr Drug Targets CNS Neurol Disord 3:81\u201390","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"322_CR305","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.289.1.65","volume":"289","author":"E Tronvik","year":"2003","unstructured":"Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 289:65\u201369","journal-title":"JAMA"},{"key":"322_CR306","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1212\/WNL.56.10.1273","volume":"56","author":"C Tzourio","year":"2001","unstructured":"Tzourio C, El Amrani M, Poirier O, Nicaud V, Bousser MG, Alperovitch A (2001) Association between migraine and endothelin type A receptor (ETA \u2212231 A\/G) gene polymorphism. Neurology 56:1273\u20131277","journal-title":"Neurology"},{"key":"322_CR307","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0304-3940(85)90296-4","volume":"62","author":"R Uddman","year":"1985","unstructured":"Uddman R, Edvinsson L, Ekman R, Kingman T, McCulloch J (1985) Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett 62:131\u2013136","journal-title":"Neurosci Lett"},{"key":"322_CR308","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1468-2982.1997.1705596.x","volume":"17","author":"LL Ven van de","year":"1997","unstructured":"van de Ven LL, Franke CL, Koehler PJ (1997) Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study. Cephalalgia 17:596\u2013599","journal-title":"Cephalalgia"},{"key":"322_CR309","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1468-2982.2002.00295.x","volume":"22","author":"RWM Broek van den","year":"2002","unstructured":"van den Broek RWM, Bhalla P, MaassenVanDenBrink A, de Vries R, Sharma HS, Saxena PR (2002) Characterization of sumatriptan-induced contractions in human isolated blood vessels using selective 5-HT1B and 5-HT1D receptor antagonists and in situ hybridization. Cephalalgia 22:83\u201393","journal-title":"Cephalalgia"},{"key":"322_CR310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/WCO.0b013e3281338d1f","volume":"20","author":"AM Maagdenberg van den","year":"2007","unstructured":"van den Maagdenberg AM, Haan J, Terwindt GM, Ferrari MD (2007) Migraine: gene mutations and functional consequences. Curr Opin Neurol 20:299\u2013305","journal-title":"Curr Opin Neurol"},{"key":"322_CR311","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/0024-3205(95)02224-7","volume":"57","author":"HM Vargas","year":"1995","unstructured":"Vargas HM, Gorman AJ (1995) Vascular \u03b11 adrenergic receptor subtypes in the regulation of arterial pressure. Life Sci 57:2291\u20132308","journal-title":"Life Sci"},{"key":"322_CR312","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00210-007-0179-1","volume":"376","author":"CM Villal\u00f3n","year":"2007","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D (2007) Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors\/mechanisms involved and therapeutic implications. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 376:45\u201363","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"322_CR313","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(90)94123-F","volume":"190","author":"CM Villal\u00f3n","year":"1990","unstructured":"Villal\u00f3n CM, Bom AH, Heiligers JPC, Den Boer MO, Saxena PR (1990) Constriction of porcine arteriovenous anastomoses by indorenate is unrelated to 5-HT1A, 5-HT1B, 5-HT1C or 5-HT1D receptor subtypes. Eur J Pharmacol 190:167\u2013176","journal-title":"Eur J Pharmacol"},{"key":"322_CR314","first-page":"199","volume":"45","author":"CM Villal\u00f3n","year":"2002","unstructured":"Villal\u00f3n CM, Centuri\u00f3n D, Valdivia LF, De Vries P, Saxena PR (2002) An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proc West Pharmacol Soc 45:199\u2013210","journal-title":"Proc West Pharmacol Soc"},{"key":"322_CR315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0773.2003.920406.x","volume":"92","author":"CM Villal\u00f3n","year":"2003","unstructured":"Villal\u00f3n CM, Ram\u00edrez-San Juan E, Sanchez-Lopez A, Bravo G, Willems EW, Saxena PR, Centuri\u00f3n D (2003) Pharmacological profile of the vascular responses to dopamine in the canine external carotid circulation. Pharmacol Toxicol 92:165\u2013172","journal-title":"Pharmacol Toxicol"},{"key":"322_CR316","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.fjc.0000159639.59770.36","volume":"45","author":"A Wackenfors","year":"2005","unstructured":"Wackenfors A, Jarvius M, Ingemansson R, Edvinsson L, Malmsjo M (2005) Triptans induce vasoconstriction of human arteries and veins from the thoracic wall. J Cardiovasc Pharmacol 45:476\u2013484","journal-title":"J Cardiovasc Pharmacol"},{"key":"322_CR317","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0026-895X(25)09495-7","volume":"38","author":"RL Weinshank","year":"1990","unstructured":"Weinshank RL, Zgombick JM, Macchi M, Adham N, Lichtblau H, Branchek TA, Hartig PR (1990) Cloning, expression, and pharmacological characterization of a human \u03b12B-adrenergic receptor. Mol Pharmacol 38:681\u2013688","journal-title":"Mol Pharmacol"},{"key":"322_CR318","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/jpet.106.101428","volume":"318","author":"B Weiss","year":"2006","unstructured":"Weiss B, Alt A, Ogden AM, Gates M, Dieckman DK, Clemens-Smith A, Ho KH, Jarvie K, Rizkalla G, Wright RA, Calligaro DO, Schoepp D, Mattiuz EL, Stratford RE, Johnson B, Salhoff C, Katofiasc M, Phebus LA, Schenck K, Cohen M, Filla SA, Ornstein PL, Johnson KW, Bleakman D (2006) Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo. J Pharmacol Exp Ther 318:772\u2013781","journal-title":"J Pharmacol Exp Ther"},{"key":"322_CR319","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/bmj.3.5982.516","volume":"3","author":"KMA Welch","year":"1975","unstructured":"Welch KMA, Chabi E, Bartosh K, Achar VS, Meyer JS (1975) Cerebrospinal fluid gamma aminobutyric acid levels in migraine. Br Med J 3:516\u2013517","journal-title":"Br Med J"},{"key":"322_CR320","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0705448","volume":"140","author":"RE Widdop","year":"2003","unstructured":"Widdop RE, Jones ES, Hannan RE, Gaspari TA (2003) Angiotensin AT2 receptors: cardiovascular hope or hype. Br J Pharmacol 140:809\u2013824","journal-title":"Br J Pharmacol"},{"key":"322_CR321","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/sj.bjp.0703915","volume":"132","author":"EW Willems","year":"2001","unstructured":"Willems EW, Valdivia LF, Saxena PR, Villal\u00f3n CM (2001a) The role of several \u03b11- and \u03b12-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation. Br J Pharmacol 132:1292\u20131298","journal-title":"Br J Pharmacol"},{"key":"322_CR322","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1468-2982.2001.00167.x","volume":"21","author":"EW Willems","year":"2001","unstructured":"Willems EW, Heiligers JPC, De Vries P, Kapoor K, Tom B, Villal\u00f3n CM, Saxena PR (2001b) \u03b11-Adrenoceptor subtypes mediating vasoconstriction in the carotid circulation of anaesthetized pigs: possible avenues for antimigraine drug development. Cephalalgia 21:110\u2013119","journal-title":"Cephalalgia"},{"key":"322_CR323","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1358\/dnp.2002.15.3.704687","volume":"15","author":"EW Willems","year":"2002","unstructured":"Willems EW, Valdivia LF, Villal\u00f3n CM, Saxena PR (2002) \u03b1-Adrenoceptors and acute migraine therapy. Drug News Perspect 15:140\u2013146","journal-title":"Drug News Perspect"},{"key":"322_CR324","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1468-2982.2003.00547.x","volume":"23","author":"EW Willems","year":"2003","unstructured":"Willems EW, Valdivia LF, Villal\u00f3n CM, Saxena PR (2003) Possible role of alpha-adrenoceptor subtypes in acute migraine therapy. Cephalalgia 23:245\u2013257","journal-title":"Cephalalgia"},{"key":"322_CR325","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0333102491011S1182","volume":"11","author":"R W\u00fcrz","year":"1991","unstructured":"W\u00fcrz R, Benmalek R, Grotemeyer KH, Foh M (1991) Bisoprolol and metoprolol in the prophylactic treatment of migraine with and without aura\u2014a randomized double-blind cross-over multicenter study. Cephalalgia 11:152\u2013153","journal-title":"Cephalalgia"},{"key":"322_CR326","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","volume":"332","author":"M Yanagisawa","year":"1988","unstructured":"Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411\u2013415","journal-title":"Nature"},{"key":"322_CR327","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0003-9969(01)00107-8","volume":"47","author":"CY Yu","year":"2002","unstructured":"Yu CY, Boyd NM, Cringle SJ, Su EN, Alder VA, Yu DY (2002) Agonist-induced vasoactive responses in isolated perfused porcine dental pulpal arterioles. Arch Oral Biol 47:99\u2013107","journal-title":"Arch Oral Biol"},{"key":"322_CR328","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2202-6-13","volume":"6","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Bhavnani BR (2005) Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci 6:13","journal-title":"BMC Neurosci"},{"key":"322_CR329","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1523\/JNEUROSCI.4542-06.2007","volume":"27","author":"Z Zhang","year":"2007","unstructured":"Zhang Z, Winborn CS, Marquez de Prado B, Russo AF (2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27:2693\u20132703","journal-title":"J Neurosci"},{"key":"322_CR330","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0304-3959(02)00027-1","volume":"97","author":"K Zimmermann","year":"2002","unstructured":"Zimmermann K, Reeh PW, Averbeck B (2002) ATP can enhance the proton-induced CGRP release through P2Y receptors and secondary PGE2 release in isolated rat dura mater. Pain 97:259\u2013265","journal-title":"Pain"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-008-0322-7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:44:19Z","timestamp":1738284259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-008-0322-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,15]]},"references-count":330,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["322"],"URL":"https:\/\/doi.org\/10.1007\/s00210-008-0322-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,15]]}}}